DS Healthcare (DSKX) 10-K 4 Apr 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 19, 2014	Jun. 28, 2013
Document and Entity Information [Abstract]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Entity Registrant Name	'DS HEALTHCARE GROUP, INC.	'	'
Entity Central Index Key	'0001463959	'	'
Current Fiscal Year End Date	'--12-31	'	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Units Outstanding	'	16,067,755	'
Entity Public Float	'	'	$9,526,788

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets	'	'
Cash	$2,872,946	$412,488
Accounts receivable, net	2,229,329	2,125,641
Inventories	2,702,579	3,453,950
Prepaid expenses and other current assets	289,885	159,164
Total Current Assets	8,094,739	6,151,243
Furniture and Equipment, net	206,958	293,720
Advances to Affiliates	'	17,973
Intangible Assets, net	1,346,389	1,674,852
Other Assets	66,506	86,888
TOTAL ASSETS	9,714,592	8,224,676
Current Liabilities	'	'
Accounts payable	2,230,723	2,327,540
Accrued expenses	945,949	704,882
Credit facility	582,383	448,658
Shareholder loans	'	353,000
Other current liabilities	286,282	227,407
Total Current Liabilities	4,045,337	4,061,487
Long Term Debt, net of current portion	36,425	45,177
TOTAL LIABILITIES	4,081,762	4,106,664
COMMITMENTS AND CONTINGENCIES	'	'
Shareholders' Equity	'	'
Preferred stock, $0.001 par value, 30 million shares authorized: 0 and 5,500,000 shares issued and outstanding at December 31, 2013 and 2012, respectively	'	5,500
Common stock, $0.001 par value, 300 million shares authorized: 15,843,005 and 12,119,705 shares issued and outstanding at December 31, 2013 and 2012, respectively	15,843	12,120
Additional paid-in-capital	14,163,595	9,244,748
Stock subscription	-194,500	-30,000
Accumulated deficit	-8,307,420	-5,097,990
Other comprehensive income	-12,462	'
Total Shareholder's Equity	5,665,056	4,134,378
Non-Controlling Interest	-32,226	-16,366
Total Shareholder's Equity	5,632,830	4,118,012
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$9,714,592	$8,224,676

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED BALANCE SHEETS [Abstract]	'	'
Preferred stock, par value per share	$0.00	$0.00
Preferred stock, shares authorized	30,000,000	30,000,000
Preferred stock, shares issued	0	5,500,000
Preferred stock, shares outstanding	0	5,500,000
Common stock, par value per share	$0.00	$0.00
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	15,843,005	12,119,705
Common stock, shares outstanding	15,843,005	12,119,705

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]	'	'
Net revenue	$13,651,661	$11,224,424
Cost of Goods Sold	6,943,043	6,749,657
Gross Profit	6,708,618	4,474,767
Selling and marketing	'	'
Commissions and consulting	1,473,194	1,818,937
Other selling and marketing expenses	2,274,019	2,017,603
Total selling and marketing	3,747,213	3,836,540
General and administrative	'	'
Salary and personnel costs	2,351,953	1,662,481
Professional fees and consulting costs	1,744,250	1,385,348
Other general and administrative expenses	2,157,967	1,201,641
Total general and administrative	6,254,170	4,249,470
Total operating costs and expenses	10,001,383	8,086,010
Operating Loss	-3,292,765	-3,611,243
Other Income (Expense)	'	'
Interest income	'	2,172
Interest expense	-115,150	-50,305
Other	278,658	36,266
Total other income (expense)	163,508	-11,867
Loss Before Income Taxes	-3,129,257	-3,623,110
Income Tax Expense	96,033	'
Net Loss	-3,225,290	-3,623,110
Net Loss Attributable to Non-Controlling Interest	-15,859	-16,366
Net Loss Attributable to Shareholders	($3,209,431)	($3,606,744)
Basic and Diluted Earnings per Share:	'	'
Weighted average shares outstanding	12,711,417	11,106,145
Loss per share	($0.25)	($0.33)

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities:	'	'
Net Loss	($3,225,290)	($3,623,110)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	607,018	293,023
Amortization of deferred issuance costs	75,891	'
Loss on disposal of fixed assets	21,637	'
Impairment of intangible assets	88,910	'
Bad debt allowance	90,045	94,534
Inventory obsolescence allowance	49,720	500,000
Stock issued for services	717,981	704,448
Warrants issued for services	'	132,070
Loss on extinguishment of debt - shareholder	289,600	'
Changes in operating assets and liabilities:	'	'
Accounts receivable	-193,733	48,800
Inventory	701,651	-1,619,788
Prepaid expenses and other current assets	-206,612	-130,961
Accounts payable	-296,816	874,323
Accrued expenses	241,067	472,914
Other current liabilities	58,874	443,574
Net cash used in operating activities	-980,057	-1,810,173
Cash Flows from Investing Activities:	'	'
Purchases of furniture and equipment	-46,794	-160,753
Purchase of injection molds	-35,139	-38,426
Disposal of Brazil Joint Venture	'	4,678
Purchase of brand rights	'	-143,847
Purchase of Mexican distributor	'	297,452
Security deposits	-25	-36,144
Net cash used in investing activities	-81,958	-77,040
Cash Flows from Financing Activities	'	'
Net proceeds of credit facility	133,725	448,658
Proceeds of notes payable	'	53,900
Proceeds of shareholders' loans	310,000	'
Repayment of loans and notes, primarily shareholder loans	-117,752	'
Repayment from related parties	17,973	'
Proceeds from sale of stock subscription	10,000	'
Proceeds from sale of stock	421,300	732,000
Less issuance cost	-31,260	-146,400
Proceeds from private placement	2,942,000	'
Less issuance cost	-151,051	'
Stock returned and cancelled	'	-72,800
Net cash provided by financing activities	3,534,935	1,015,358
Effect of exchange rate changes on cash	-12,462	'
Increase (decrease) in cash	2,460,458	-871,855
Cash, Beginning of Period	412,488	1,284,343
Cash, End of Period	2,872,946	412,488
Supplemental Information:	'	'
Cash paid for interest	19,745	42,160
Supplemental Noncash Investing and Financing Activities:	'	'
Stock issued to settle debt	554,000	'
Conversion of preferred shares	5,500	'
Stock issued for purchase of Mexican distributor	'	$1,303,000

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (USD $)	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid In Capital [Member]	Subscription/Stock Receivable [Member]	Accumulated Deficit [Member]	Other Comprehensive Income [Member]	Total Shareholders' Equity [Member]	Non-Controlling Interest [Member]
Balance at Dec. 31, 2011	$5,005,246	$10,000	$10,503	$6,606,668	($100,000)	($1,506,893)	'	$5,020,278	($15,032)
Balance, shares at Dec. 31, 2011	'	10,000,000	10,502,961	'	'	'	'	'	'
Shares Issued:	'	'	'	'	'	'	'	'	'
Sold to private investors	732,000	'	292	731,708	'	'	'	732,000	'
Sold to private investors, shares	'	'	292,000	'	'	'	'	'	'
Less: Issuance costs	-146,400	'	'	-146,400	'	'	'	-146,400	'
For services	'	'	'	'	'	'	'	'	'
Investor relations	307,394	'	105	237,289	70,000	'	'	307,394	'
Investor relations, shares	'	'	104,697	'	'	'	'	'	'
Employee/associate compensation	158,915	'	58	158,857	'	'	'	158,915	'
Employee/associate compensation, shares	'	'	58,249	'	'	'	'	'	'
Distributor award	234,138	'	79	234,060	'	'	'	234,138	'
Distributor award, shares	'	'	78,704	'	'	'	'	'	'
Consulting	4,000	'	2	3,998	'	'	'	4,000	'
Consulting, shares	'	'	2,000	'	'	'	'	'	'
Purchase Mexican distributor	1,303,000	'	600	1,302,400	'	'	'	1,303,000	'
Purchase Mexican distributor, shares	'	'	600,000	'	'	'	'	'	'
Fair value adjustment of Mexican distributors	2,879	'	'	2,879	'	'	'	2,879	'
Purchase brand rights	50,000	'	15	49,985	'	'	'	50,000	'
Purchase brand rights, shares	'	'	15,385	'	'	'	'	'	'
Fractional shares from reverse split	'	'	9	'	'	'	'	'	'
Shares Cancelled / Surrendered:	'	'	'	'	'	'	'	'	'
Issued in error and returned	-56,000	'	-20	-55,980	'	'	'	-56,000	'
Issued in error and returned, shares	'	'	-20,000	'	'	'	'	'	'
Surrendered	-16,800	'	-5	-16,795	'	'	'	-16,800	'
Surrendered, shares	'	'	-5,000	'	'	'	'	'	'
Preferred shares converted	'	-4,500	450	4,050	'	'	'	'	'
Preferred shares converted, shares	'	-4,500,000	450,000	'	'	'	'	'	'
Disposal of Brazil distribution joint venture	30,679	'	'	'	'	15,647	'	15,647	15,032
Net Loss	-3,623,110	'	'	'	'	-3,606,744	'	-3,606,744	-16,366
Balance at Dec. 31, 2012	4,118,012	5,500	12,120	9,244,748	-30,000	-5,097,990	'	4,134,378	-16,366
Balance, shares at Dec. 31, 2012	'	5,500,000	12,119,705	'	'	'	'	'	'
Shares Issued:	'	'	'	'	'	'	'	'	'
Sold to private investors	421,300	'	390	423,410	-2,500	'	'	421,300	'
Sold to private investors, shares	'	'	390,135	'	'	'	'	'	'
Less: Issuance costs	-31,260	'	'	-31,260	'	'	'	-31,260	'
Private investment in public equity	2,942,000	'	1,965	3,142,035	-202,000	'	'	2,942,000	'
Private investment in public equity, shares	'	'	1,965,000	'	'	'	'	'	'
Less: Issuance costs	-151,051	'	'	-151,051	'	'	'	-151,051	'
For services	'	'	'	'	'	'	'	'	'
Investor relations	323,383	'	161	293,222	30,000	'	'	323,383	'
Investor relations, shares	'	'	161,033	'	'	'	'	'	'
Employee/associate compensation	102,721	'	53	102,668	'	'	'	102,721	'
Employee/associate compensation, shares	'	'	53,424	'	'	'	'	'	'
Distributor award	229,225	'	120	229,105	'	'	'	229,225	'
Distributor award, shares	'	'	120,199	'	'	'	'	'	'
Consulting	'	'	'	'	'	'	'	'	'
Board of Directors	62,651	'	28	62,623	'	'	'	62,651	'
Board of Directors, shares	'	'	27,500	'	'	'	'	'	'
Fractional shares from reverse split	'	'	9	'	'	'	'	'	'
Subscriptions sold, shares not Issued:	'	'	'	'	'	'	'	'	'
Sold to private investors, subscriptions	10,000	'	'	'	10,000	'	'	10,000	'
Less: Issuance costs, subscriptions	'	'	'	'	'	'	'	'	'
Shares Cancelled / Surrendered:	'	'	'	'	'	'	'	'	'
Preferred shares converted	'	-5,500	550	4,950	'	'	'	'	'
Preferred shares converted, shares	'	-5,500,000	550,000	'	'	'	'	'	'
Shareholder loan converted	843,600	'	456	843,144	'	'	'	843,600	'
Shareholder loan converted, shares	'	'	456,000	'	'	'	'	'	'
Other comprehensive income	-12,462	'	'	'	'	'	-12,462	-12,462	'
Net Loss	-3,225,290	'	'	'	'	-3,209,431	'	-3,209,431	-15,859
Balance at Dec. 31, 2013	$5,632,830	'	$15,843	$14,163,593	($194,500)	($8,307,421)	($12,462)	$5,665,053	($32,225)
Balance, shares at Dec. 31, 2013	'	'	15,843,005	'	'	'	'	'	'

ORGANIZATION_AND_NATURE_OF_BUS

ORGANIZATION AND NATURE OF BUSINESS	12 Months Ended
	Dec. 31, 2013
ORGANIZATION AND NATURE OF BUSINESS [Abstract]	'
ORGANIZATION AND NATURE OF BUSINESS	'
	NOTE 1. - ORGANIZATION AND NATURE OF BUSINESS
	Terms and Definitions
		AICPA	American Institute of Certified Public Accountants
		ASC	Accounting Standards Codification
		ASU	Accounting Standards Update
		FASB	Financial Accounting Standards Board
		FIFO	First-in, First-out
		US GAAP	Accounting principles generally accepted in the United States of America
		IFRS	International Financial Reporting Standards
		SEC	Securities Exchange Commission
		SFAS or FAS	Statement of Financial Accounting Standards
		2013-YTD	Year ended December 31, 2013
		2012-YTD	Year ended December 31, 2012
		VIE	Variable Interest Entity
	Organization and Nature of Business
	DS Healthcare Group, Inc. (d/b/a DS Laboratories) (the "Company", "DS Laboratories", "DSKX", "we", "us" or "our") was organized under the laws of the State of Florida in January 2007. Through its predecessors, the Company has been developing and marketing hair care, skin care and personal care products for over fifteen years. The Company has grown steadily over the last few years with a network of top specialty retailers and distributors throughout North America, Europe, Asia and South America. The Company researches and develops its own products, which management believes keeps the Company at the forefront of innovation. Management believes the Company is currently a leading innovator of (1) "Liposome Technology", which acts as a carrier agent, and has been designed to enhance the action of the active ingredients in our products, and (2) "Nanosome Technology", which acts as a delivery vehicle, and has been designed to infuse active compounds into targeted cells for increased efficiency of our products. We currently offer products are within the following broad product categories:  Hair Care, Skin Care and Personal Care.
	History of the Company
	The Company was incorporated in January 2007 and capitalized with the assets recovered from a terminated predecessor New York corporation. DS Laboratories, Inc. (a Florida corporation) was also incorporated in January 2007. The companies were founded by common shareholders.
	The preliminary operating entity is DS HealthCare Group, Inc. and currently conducts its business under the "DS Laboratories" and "Divine Skin" trade names.
	In 2009, the Company acquired its subsidiaries, Polaris Labs, Inc. ("Polaris"), Sigma Development and Holding, Inc. ("Sigma") DS Laboratories, Inc. ("DS Labs") for a nominal amount.  Also in 2009, we completed an agreement with DS Laboratories Brazil, LTDA to distribute our products and additional future products specifically tailored for the Brazilian market for a term of 10 years. The costs associated with procuring this agreement have been capitalized and are amortized over the life of the agreement.
	In 2011, we began distribution of Nutra Origin brand nutraceutical products under an exclusive distribution agreement with the manufacturer.  We also modified our joint venture distribution agreement so that in exchange for 100% ownership in the joint venture, our Brazilian distributor has fully funded the product development and licensing of our products in Brazil. We will remain the license holder once the license is granted and we retain our exclusivity for Brazilian distribution.
	In the second quarter of 2012, we engaged in negotiations to license or acquire the Nutra Origin brand. Negotiations were completed and closed in the fourth quarter of 2012 whereby we pay $7,500 per month for an exclusive 10 year license to use the Nutra Origin brand. As part of the closing, we issued $50,000 in DSKX stock and granted a 7% equity interest in a newly formed subsidiary, Nutra Origin, Inc. In a separate transaction, we also acquired the 100% of the Pure Guild brand license (see Note 7).
	In the fourth quarter of 2012, we closed on the acquisition of Divine Skin Laboratories, S.A. de CV, our Mexican Distributor ("DS Mexico") (see Note 20).  Also in the fourth quarter of 2012, we completed a 10:1 reverse split and effected a name change to DS Healthcare Group, Inc. All share, share equivalent and per share information contained in this report gives retroactive effect to the 10:1 reverse split.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 2. - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of Consolidation and Presentation
	The consolidated financial statements are prepared using the accrual basis of accounting where revenues and expenses are recognized in the period in which they were incurred. The basis of accounting conforms to accounting principles generally accepted in the United States of America.
	The consolidated financial statements include the accounts of the Company and its operating subsidiaries DS Laboratories, Inc., Sigma Development and Holding Co., Inc., Polaris Labs, Inc., Nutra Origin, Inc. and Divine Skin Laboratories, S.A. de CV. Also included in the consolidated financial statements are the operating activities of Velocity Storage and Packaging, LLC and Wally Group, LLC an inactive entity, which are accounted for as VIEs. All significant intercompany balances and transactions have been eliminated in consolidation.
	Prior Period Reclassifications
	Certain prior period amounts that were combined in the December 31, 2012 consolidated financial statements have been reclassified for comparability with the December 31, 2013 presentation. These reclassifications had no effect on previously reported net loss.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. We believe our estimates and assumptions are reasonable; however, such estimates and assumptions are subject to a number of risks and uncertainties that may cause actual results to differ materially from such estimates. Significant estimates and assumptions underlying these consolidated financial statements include:
	·	Estimates of allowances for uncollectable accounts receivable,
	·	Estimates of inventory obsolescence and overhead and labor cost allocations,
	·	Estimates assuming future earning capacity of our intangible assets,
	·	Estimates of value of equity transactions for services rendered,
	·	Estimates of returned or damaged product, and
	·	Estimates made in our deferred income tax calculations.
	Risks and Uncertainties
	The Company's business could be impacted by price pressure on its product manufacturing, acceptance of its products in the market place, new competitors, changes in federal and/or state legislation and other factors. The Company also has been experiencing significant growth which puts serious strains on its cash availability requirements. If the Company is unsuccessful in securing adequate liquidity, its plans may be curtailed. Adverse changes in these areas could negatively impact the Company's financial position, results of operations and cash flows.
	Business Acquisitions
	Acquired businesses are accounted for using the acquisition method of accounting. The acquisition method of accounting for acquired businesses requires, among other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date. The excess of the purchase price over the assigned values of the net assets acquired, if any, is recorded as goodwill. Transaction costs are expensed as incurred.
	Cash
	The Company maintains its cash and cash equivalents in financial institutions located in the United States. At times, the Company's cash and cash equivalent balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limits. The Company has not experienced any losses in such accounts.
	Accounts Receivable
	Accounts receivable are reported at their net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. The Company also provides for allowances against accounts receivables for product returns and cooperative advertising allowances. At December 31, 2013 and 2012, the allowance for uncollectable accounts was $305,314 and $373,981, respectively, $210,000 and $110,000 respectively for defectives and product returns and $60,000 at both dates for advertising credits.
	Inventory
	Inventory is reported at the lower of cost or market on the FIFO method. Our inventory is subject to expiration and obsolescence. Accordingly, quantities purchased and sell through rates are periodically monitored for potential overstocking or pending expiration as a basis for establishing the appropriate reserve for any estimated expiration or obsolescence.
	Furniture and Equipment
	Furniture and equipment are recorded at cost and depreciation is provided using the double declining balance depreciation method in the United States and the straight line depreciation method in Mexico over the estimated useful lives of the assets, which range from 5 to 7 years. The Company recorded $111,919 and $46,678 in depreciation expense during 2013-YTD and 2012-YTD, respectively. Accumulated depreciation was $238,051 and $101,972 at December 31, 2013 and 2012, respectively. Expenditures for repairs and maintenance of equipment are charged to expense as incurred. Major replacements and betterments are capitalized and depreciated over the remaining useful lives of the assets.
	Long-Lived Assets
	Long-lived assets and certain identifiable intangibles held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset.  Assets disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.
	Intangible Assets
	Intangible assets acquired individually, with a group of other assets, or in a business combination, are recorded at fair value. The Company's identifiable intangible assets consist of customer relationships acquired as part of the Merger. The fair value of intangible assets acquired was determined based on a discounted cash flow analysis. Identifiable intangible assets are being amortized over the period of estimated benefit using the straight-line method, which approximates the customer attrition rate, reflecting the pattern of economic benefits associated with these assets, and have estimated useful lives between 6 and 10 years.
	Goodwill
	The Company records goodwill when the purchase price of an acquisition exceeds the fair value of the net tangible and intangible assets as of the date of acquisition. The Company performs an annual review of goodwill for indicators of impairment. When it is determined that goodwill may be impaired, the Company performs an impairment assessment of the acquired reporting unit and impairment tests using a fair value approach. As of December 31, 2013, the Company has not identified any such impairment.
	Non-Controlling Interest
	Non-controlling interest consists of the minority owned portion of Nutra Origin, Inc. During the fourth quarter of 2012, the Company completed its license of the Nutra Origin brand. In addition, the Company established a new subsidiary to operate the Nutra Origin brand. As part of the license agreement, the licensor was granted a 7% non-controlling interest in the newly formed subsidiary.  The Company is currently in default of its license agreement for non-payment and has fully impaired related brand rights of $89,705.
	Revenue Recognition
	Revenue is recognized when a product is shipped and risk of loss is transferred. The Company manages the collection process for transactions processed on its website, but it outsources its fulfillment (delivery) process to third parties.  The Company's revenue recognition policies are in compliance with ASC Topic 605, "Revenue Recognition", which establishes criteria that must be satisfied before revenue is realized or realizable and earned. The Company recognizes revenue when all of the following four criteria are met:
	·	persuasive evidence of a sales arrangement exists,
	·	delivery has occurred,
	·	the sales price is fixed or determinable and
	·	collectability is probable.
	Shipping and handling charges related to sales transactions are recorded as sales revenues when billed to customers or included in the sales price.  Shipping and handling costs are included in cost of goods sold.
	Research and Development
	The Company currently maintains a functional laboratory employing two full time chemists, a part time chemist/consultant and a lab technician that identify new technology, test product alternatives and improve existing formulations. In addition, our founder and CEO devotes a substantial portion of his time in identifying new technologies and formulations to develop new products and improve existing products with the newest technology available. Such activities are expensed in the year incurred. Such costs include laboratory supplies, salaries, materials and consultant fees. These costs are classified as product development, salaries, selling, general and administrative expenses in the consolidated statements of operations, and amounted to $170,451 and $196,108 for 2013-YTD and 2012-YTD, respectively.
	Share-Based Payment
	The Company measures compensation cost for all employee stock-based awards at their fair values on the date of grant. Stock-based awards issued to non-employees are measured at their fair values on the date of grant, and are re-measured at each reporting period through their vesting dates. When a non-employee becomes an employee and continues to vest in the award, the fair value of the individual's award is re-measured on the date that he becomes an employee, and then is not subsequently re-measured at future reporting dates. The fair value of stock based awards is recognized as expense over the service period, net of estimated forfeitures, using the straight-line method for stock options and restricted stock. The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock-based awards.
	Income Taxes
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. A valuation allowance is recorded when it is more likely than not that some portion or all of a deferred tax asset will not be realized,  At December 31, 2013 and 2012, a full valuation allowance was provided against our deferred tax assets.  Income tax expense is the result of Mexican operations.
	Earnings per share
	The Company computes basic and diluted earnings per share amounts in accordance with ASC Topic 260, "Earnings per Share". Basic earnings per share is computed by dividing net income (loss) attributable to shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. Vested warrants for 253,893 shares and vested options for 32,633 shares were excluded from the earnings per share calculation because they would be anti-dilutive.
	Segment Information
	ASC Topic 280, "Disclosures about Segments of an Enterprise and Related Information," established standards for the way that public business enterprises report information about operating segments in annual financial statements and requires those enterprises to report selected information about operating segments in interim financial reports issued to stockholders. Management has determined that the Company operates in one business segment, which is the commercialization and development of personal care products.
	Fair Value of Financial Instruments
	Fair value is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. We currently do not have any financial assets and liabilities that are recurring that would require us to disclose them at fair value.
	Subsequent Events
	Management has evaluated subsequent events or transactions occurring through the date the financial statements were issued. Management concluded that no additional subsequent events required disclosure in these financial statements other than those disclosed in these notes to these financial statements.
	Functional Currency
	The U.S. dollar is the functional currency of our consolidated entities operating in the United States. The functional currency for our consolidated entity operating outside of the United States is the Mexican peso. We translate their financial statements into U.S. dollars as follows:
	·	Assets and liabilities are translated at the exchange rate in effect as of the financial statement date.
	·	Income statement accounts are translated using the weighted average exchange rate for the period.
	We include translation adjustments from currency exchange and the effect of exchange rate changes on intercompany transactions of a long-term investment nature as a separate component of shareholders' equity. There are currently no transactions of a long-term investment nature, nor any gains or losses from non-U.S. currency transactions.

LIQUIDITY

LIQUIDITY	12 Months Ended
	Dec. 31, 2013
LIQUIDITY [Abstract]	'
LIQUIDITY	'
	NOTE 3. - LIQUIDITY
	We have sustained operational losses since our inception, and such operational losses have continued through December 31, 2013 At December 31, 2013, we had an accumulated deficit of approximately $8,307,420. The Company cannot predict how long it will continue to incur further losses or whether it will ever become profitable which is dependent upon the reduction of certain operating expenses, success of new and existing products and increase in overall revenue. These conditions raise substantial doubt about the entity's ability to continue as a going concern.
	However, as of December 31, 2013, we had $2,872,946 in cash. While we have historically financed our operations and growth primarily through the successful issuance and sale of shares of our common stock, a line of credit and the issuance of promissory notes, the Company has started several new revenue initiatives creating additional revenue streams for the Company.  Some of these initiatives include; establish an online store, establish a physical retail store, establish a hair treatment clinic, complete a private label product for a fortune 500 healthcare company, increase our domestic and international presence. Although we cannot predict our success with these products and or projects, all are currently under way and in various stages of completion. We have commenced implementing, and will continue to implement, various measures to address our financial condition, including but not limited to:
	·	Continuing to seek debt and equity financing. However, there can be no assurances that the Company will be able to raise additional capital on favorable terms, or at all.
	·	We completed an operational budget for 2014 that sets changes in our processes to focus on profitability in 2014.  We are also implementing a feedback process with improved interdepartmental communication.
	Accordingly, the accompanying consolidated financial statements have been prepared in conformity with US GAAP, which contemplates continuation of the Company as a going concern.  The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and carrying amount or classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. We have commenced implementing, and will continue to implement, various measures to address our financial condition.

RECENT_ACCOUNTING_PRONOUNCEMEN

RECENT ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Dec. 31, 2013
RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]	'
RECENT ACCOUNTING PRONOUNCEMENTS	'
	NOTE 4. - RECENT ACCOUNTING PRONOUNCEMENTS
	In February 2013, the FASB issued ASU 2013-02, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income,". The amendments in this update require an entity to provide information about the amounts reclassified from accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the income statement or in the notes thereto, significant amounts reclassified from accumulated other comprehensive income by the respective net income line item. This new guidance is to be applied prospectively for interim and annual periods beginning after December 15, 2012. The adoption of ASU 2013-02 did not have a material impact on the Company's consolidated financial statements.
	In March 2013, FASB issued ASU 2013-05, "Foreign Currency Matters: Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity," an amendment which allows an entity to release cumulative translation adjustment into net income when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. This is effective for fiscal years and interim reporting periods beginning after December 15, 2013, with early adoption permitted. The adoption of this guidance did not have a material impact on our consolidated financial statements or related disclosures.
	In July 2013, the FASB issued ASU 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,". The amendments in this update require that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except under a few limited circumstances. The amendments in this update do not require new recurring disclosures. This new guidance is to be applied prospectively for interim and annual periods beginning after December 15, 2013. The adoption of ASU 2013-11 did not have a material impact on the Company's consolidated financial statements.
	Management continually evaluates the potential impact, if any, of all recent accounting pronouncements on our consolidated financial statements or related disclosures and, if significant, makes the appropriate disclosures required by such new accounting pronouncements.

INVENTORY

INVENTORY	12 Months Ended
	Dec. 31, 2013
INVENTORY [Abstract]	'
INVENTORY	'
	NOTE 5. - INVENTORY
	Significant components of inventory at December 31, 2013 and December 31, 2012 consist primarily of:
		2013			2012
	Bulk product and raw materials	$	1,930,848		$	2,402,331
	Work in process		192,319			237,284
	Merchandise inventory		965,127			1,074,833
	Inventory in transit		164,005			239,502
	Less: Allowance		(549,720	)		(500,000	)
		$	2,702,579		$	3,453,950
	Bulk product and raw materials - Bulk product consists of completed product formulations that have not yet been packaged in market ready packaging. Raw materials consist of bulk quantities of the various chemical components of our product along with bottles, pumps, labels and other packaging materials.
	Work in process - Work in process inventory consists of merchandise inventory currently in interim production stage that is partially completed and not yet market ready.
	Merchandise inventory - Merchandise inventory consists of completed formulations in market ready packaging. Our formulations are batch controlled and subject to various government regulations which, among other things, govern the purity and safety of our product.
	Inventory in transit - In transit inventory consists of primarily bulk product and raw materials where title has transferred to the Company but the inventory has yet to arrive in a designated warehouse facility either Company owned or under contract.
	Management evaluated the inventory at December 31, 2013 and 2012 and reserved $549,720 and $500,000, respectively, as an allowance for slow moving and obsolete inventory. The allowance applies primarily to bulk product and raw materials where the chemical components have expired and the bottles, pumps and packaging materials are no longer being used in current production due to packaging changes or were in excess of quantities needed based on current production consumption. Generally, merchandise inventory does not require a reserve.

PREPAID_EXPENSES_AND_OTHER_CUR

PREPAID EXPENSES AND OTHER CURRENT ASSETS	12 Months Ended
	Dec. 31, 2013
PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]	'
PREPAID EXPENSES AND OTHER CURRENT ASSETS	'
	NOTE 6. - PREPAID EXPENSES AND OTHER CURRENT ASSETS
	Prepaid expenses and other current assets at December 31, 2013 and December 31, 2012 consist primarily of:
		2013		2012
	Prepaid rent	$	28,620	$	21,200
	Prepaid insurance		38,523		24,304
	Deferred financing costs, net of amortization		4,688		61,828
	Prepaid value added tax		12,059		30,228
	Employee advances		11,500		-
	Other receivables		126,126		-
	Prepaid board fees		15,150		-
	Pending VAT and other advances		53,219		21,604
		$	289,885	$	159,164
	Prepaid rent - Represents the temporary timing of rent payments.
	Prepaid insurance - Represents the temporary advance of deposits and scheduled premium payments made in excess of premiums expensed over the policy period. Premiums advanced and expensed during 2013-YTD totaled approximately $111,960 and $77,264, respectively.  Most of our insurance coverage was renewed in June 2013.
	Deferred issuance costs - These amounts were made in connection with obtaining financing arrangements from our asset based lender discussed more fully in Note 11, which consisted of loan origination fees, legal and due diligence fees. Deferred issuance costs advanced and expensed during 2013-YTD totaled approximately $18,750 and $47,908, respectively. Our lender charged a renewal fee in April 2013.
	Prepaid and pending VAT - Represents payments made and in process by our Mexican subsidiary to tax authorities for the value added tax imposed on commercial transactions.

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2013
INTANGIBLE ASSETS [Abstract]	'
INTANGIBLE ASSETS	'
	NOTE 7. - INTANGIBLE ASSETS
	Significant components of intangible assets at December 31, 2013 and December 31, 2012 consist of:
		2013			2012
	Distribution rights in Brazil	$	750,000		$	750,000
	Less: Accumulated amortization		(318,750	)		(243,750	)
	Net distribution rights		431,250			506,250
	Pure Guild brand rights		159,086			159,086
	Less: Accumulated amortization		(92,570	)		(77,790	)
	Net brand right		66,516			81,296
	Nutra Origin license		-			144,307
	Less: Accumulated amortization		-			(6,500	)
	Net license		-			137,807
	DS Mexico Customer list		932,000			932,000
	Less: Accumulated amortization		(119,662	)		(16,945	)
	Net customer list		812,338			915,055
	Goodwill		36,285			34,444
		$	1,346,389		$	1,674,852
	Brazilian distribution rights - During 2009, the Company issued 300,000 shares of common stock to a Brazilian distributor in exchange for a 10 year exclusive distribution agreement in Brazil. The transaction was valued at $2.50 per share. The Company, through its exclusive distributor, former joint venture partner and shareholder, is currently commercializing its product line along with a generic Minoxidil product for the Brazilian market, which was introduced in the 4th quarter of 2012. Such rights are being amortized over 10 years. $75,000 was amortized during the years ended December 31, 2013 and 2012.
	Pure Guild brand rights - During the 3rd quarter of 2009, we entered into an agreement with a customer/distributor to develop a private label brand of premium products and associated packaging materials. The Pure Guild brand of products was the result. As part of this project we obtained a 50% interest in the Pure Guild brand and the permanent exclusive rights to manufacture the Pure Guild products. In exchange for these rights, we provided $106,666 of product representing approximately 70% the initial stocking order. These rights were being amortized over 5 years, representing the basic term of the supplier agreement.
	During the second quarter of 2012, we acquired the remaining 50% ownership of the Pure Guild brand from our customer/distributor in exchange for release from the exclusive supplier agreement so that we may pursue promotion of the brand through our existing distributor network. As a convenience, we also accepted return of their remaining Pure Guild inventory, which amounted to $50,000, based on the original sales price. Because we have begun to revitalize the brands position in the market, we will modify the amortization term to appropriately reflect the remaining unamortized brand rights combined with the additional brand rights acquired, to 6 years. $14,780 and $20,190 has been amortized during the years ended December 31, 2013 and 2012, respectively.
	Nutra Origin brand license - We have been distributing the Nutra Origin brand products since October 2010 and although the brand currently represents a relatively modest portion of our sales, we intend for this brand to expand our health and personal care product offerings into the nutraceutical market. Our CEO's father is a part owner and was COO of the company that owns the Nutra Origin brand. He is now our Nutra Origin product manager. Our license agreement requires us to pay $7,500 per month for an exclusive 10 year license to use the Nutra Origin brand, plus $50,000 in common shares of the Company. The agreement contains certain performance clauses for both parties, which permit cancellation by us after 3 years and permit cancellation by the seller if we fail to maintain stipulated minimum sales.  We are currently delinquent in payment of our license fees. $48,102 has been amortized during the year ended December 31, 2013. In addition we have impaired the license rights and recognized a charge of $89,705 as of December 31, 2013.
	DS Mexico Customer list - In connection with the acquisition of our Mexican distributor, which is discussed more fully in Note 20, we acquired the customer list which was recorded at its fair value as determined by an independent appraiser. The asset is being amortized over its estimated useful life of 9 years. Accordingly, the Company recognized $101,670 and $16,945 of amortization expense in the year ended December 31, 2013 and December 31, 2012, respectively. The change in the gross value of the DS Mexico customer list is the result of foreign currency translation adjustment at December 31, 2013.
	Goodwill - Also in connection with the acquisition of our Mexican distributor, which is discussed more fully in Note 20, we acquired goodwill which represents the excess of the fair value of consideration given over the fair value of the assets acquired. Its fair value was determined by an independent appraiser. The asset is not being amortized; however the Company will access the asset for impairment annually. The change in the gross value of the goodwill is the result of foreign currency translation adjustment at December 31, 2013.  At December 31, 2013, no impairment was considered necessary.
	The following table represents the amortized cost of the various assets over the remaining years, the weighted average remaining period is 6.99 years.
		2014			2015			2016		2017		Beyond		Total
	Asset:
	Brazil distribution rights	$	75,000		$	75,000		$	75,000	$	75,000	$	131,250	$	431,250
	Pure Guild brand rights		14,780			14,780			14,780		14,780		7,396		66,516
	Mexican Customer list		103,500			103,500			103,500		103,500		398,338		812,338
		$	193,280		$	193,280		$	193,280	$	193,280	$	536,984	$	1,310,104

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	12 Months Ended
	Dec. 31, 2013
ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]	'
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	'
	NOTE 8. - ACCRUED EXPENSES
	Accrued expenses at December 31, 2013 and December 31, 2012 consist of:
		2013		2012
	Accrued expenses:
	Advertising and marketing	$	12,264	$	60,264
	Commissions		261,151		362,346
	Director services		18,750		---
	Facilities		12,535		38,023
	Fees / interest		21,003		19,012
	Investor relations		390,703		44,000
	Production materials		144,543		-
	Other		-		61,807
	Personnel		70,000		109,930
	Professional fees		15,000		9,500
		$	945,949	$	704,882
	Accrued expenses - Represents commitments made for goods or services provided, where the activity does not normally generate an invoice that can be recorded as a trade payable, such as accrued commissions or where invoices were received subsequent to the end of the reporting period but the goods or services were provided prior to the end of the reporting period.

OTHER_CURRENT_LIABILITIES

OTHER CURRENT LIABILITIES	12 Months Ended
	Dec. 31, 2013
OTHER CURRENT LIABILITIES [Abstract]	'
OTHER CURRENT LIABILITIES	'
	NOTE 9. - OTHER CURRENT LIABILITIES
	Other current liabilities at December 31, 2013 and December 31, 2012 consist of:
		2013		2012
	Customer deposits	$	29,959	$	22,689
	Credit cards		47,597		117,006
	VAT Taxes payable		142,848		78,989
	Current portion of long term debt		10,770		8,723
	Insurance premium financing		4,770		-
	Vendor financing		50,338		-
		$	286,282	$	227,407
	Customer deposits - represent monies advanced to us on orders for future shipments.
	Insurance premium financing - represent short term borrowings specifically to finance the acquisition of certain insurance coverage.  Our insurance coverage financed included, D&O, general liability and ocean marine coverage.
	Vendor financing - represent financing offered by vendors to fund our purchases of their product.

SHAREHOLDER_LOANS

SHAREHOLDER LOANS	12 Months Ended
	Dec. 31, 2013
SHAREHOLDER LOANS [Abstract]	'
SHAREHOLDER LOANS	'
	NOTE 10. - SHAREHOLDER LOANS
	Shareholder loans - On December 10, 2012, we received an unsecured loan for $314,000 from one of our consultants who is also a shareholder. This loan is non-interest bearing and matured on December 11, 2013. During the first quarter of 2013, we received an additional $240,000 from the same consultant/shareholder under the same terms as the initial advance, bringing the total advanced to $554,000. On September 27, 2013, the lender accepted 456,000 shares of common stock in full satisfaction of outstanding liability. The common shares issued were valued at $843,600 based on the trading values of shares at the time of issuance.  Accordingly, the Company recognized a $289,600 loss on extinguishment of debt.
	In 2012, we also received a loan from Daniel Khesin, our Chief Executive Officer for $39,000. This loan is unsecured, non-interest bearing and matured on December 25, 2013. Installment payments totaling $39,000 have been made during the year ending December 31, 2013.  As of December 31, 2013, the loan was paid in full.
	On January 20, 2013, we received an unsecured loan for $70,000 from Gamma Investors, also a shareholder and affiliate of our Brazilian distributor. The loan accrues interest at 3% per month and matured on August 20, 2013.  The loan called for monthly installment payments along with interest. As of December 31, 2013, the loan was paid in full.

DEBT_FINANCING

DEBT FINANCING	12 Months Ended
	Dec. 31, 2013
DEBT FINANCING [Abstract]	'
DEBT FINANCING	'
	NOTE 11. - DEBT FINANCING
	Credit Facility - On April 6, 2012, MidCap Finacial provided the Company with a $1.5 million credit facility with an initial draw of $580,000. The credit facility provides for asset based lending collateralized by all assets of the Company. Advances are based on 70% of qualified accounts receivable and 40% of eligible finished goods inventory. The credit facility as amended, provides for interest and bank fees, which currently aggregate to 8% (prime plus 3% plus 1.75% asset monitoring fees and other fees) per annum which has been renewed with a reduced $1.0 million credit facility and expires June 30, 2014 (See Note 21). The credit facility is personally guaranteed by our Chief Executive Officer and, under certain conditions, may be called upon demand. The credit facility also provides for a referral fee of 4% per annum for 3 years. The Loan Agreement contains customary representations, warranties, affirmative and negative covenants and events of default. The negative covenants include, among other things, restrictions on transferring our assets, incurring additional indebtedness, engaging in mergers or acquisitions, paying dividends or making other distributions, and creating other liens on our assets, in each case subject to customary exceptions. As of December 31, 2013 and 2012, the Company had $582,383 and $448,658 outstanding, respectively and $175,115 available to borrow as of December 31, 2013 based on its advance formulas for qualified accounts receivable and eligible finished goods inventory.
	Long Term Debt - On December 10, 2012, the Company entered into a loan agreement for $53,900 to purchase certain warehouse equipment. The loan provides for monthly payments of $1,041 for 60 months at 5.95% interest. Payments began on February 18, 2013. Interest expense from this loan during the years ended December 31, 2013 and 2012 was $3,138 and $0 respectively.
	Principal payout over the life of the loan is as follows:
		2014		2015		2016		2017		Total
	Long Term Debt	$	10,770	$	11,429	$	12,127	$	12,869	$	47,195

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Dec. 31, 2013

COMMITMENTS AND CONTINGENCIES [Abstract]

'

COMMITMENTS AND CONTINGENCIES

'

NOTE 12. - COMMITMENTS AND CONTINGENCIES

During the years ended December 31, 2013 and 2012, the Company operated under several material agreements as listed below:

Lease for office and production facilities -

·

The Company leased its corporate headquarters office space located in Miami Beach, Florida, on a month to month basis at $5,700 per month or $68,400 on an annual basis, which was terminated during the fourth quarter of 2012.

·

In October 2012, the Company entered into a lease, which added 1,525 square feet of additional space and renewed its existing lease for a total of 1,875 square feet in sales facilities located in Ashville, North Carolina. The leases provide for monthly rent of $4,725 throughout the lease term which both expire on December 31, 2015.

·

The Company leased 13,137 square feet of warehouse and production space in Pompano Beach, Florida. The lease provided for monthly rent of $6,350 and expired on October 15, 2012.

·

In fourth quarter of 2012, the Company entered into a lease for 50,000 square feet in warehouse and corporate office space located in Deerfield Beach, Florida. The lease provides for monthly rent of $20,000 in the first six months and $27,000 per month thereafter. The lease term is for 22 months.

The Company accounts for its facility leases using the straight-line method and incurred $408,491 and $299,406 in total rent expense in 2013 and 2012, respectively.

The Company is committed to lease payments over the next five years are as follows:

2014

2015

2016

Beyond

Total

Facility Leases:

Deerfield Beach, Florida (Production) (HQ)

$

189,000

$

-

$

-

$

-

$

189,000

Ashville, North Carolina (Sales)

56,695

56,695

-

-

113,390

$

245,695

$

56,695

$

-

$

-

$

302,390

Pending and threatened litigation -

·

The Company has received several pending and threatened litigations from various suppliers typically over non-payment for goods or services. Such vendor disputes are typical in the normal course of business. The Company has vigorously disputed those claims on the grounds of the substandard materials or services provided. In 2011, we received 5 supplier claims for certain advertising, human resource and consulting matters that we are disputing and filing counter claims. We settled four of these claims in 2012 and structured payouts representing our estimate of the amount due of $22,264 and $162,764 at December 31, 2013 and December 31, 2012, respectively.  We intend to vigorously defend the remaining claim.

·

We and our chief executive officer, individually, were named in a lawsuit brought in the Circuit Court of the 11th Judicial Circuit in and for Miami-Dade County, Florida by a former employee of Evolution Model Management, Inc. claiming wrongful termination. We were named because we originally hired the employee rather than Evolution Model Management, as the latter was not yet an established entity. On December 2, 2012, we entered into a settlement agreement and release of claims whereby we agreed to pay the plaintiff an aggregate of $77,500, payable in three equal installments. The final payment was made in April 2013.

·

We and our chief executive officer, individually, were named in a lawsuit brought in the Circuit Court of the 11th Judicial Circuit in and for Miami-Dade County, Florida in 2012 by a former contractor claiming wrongful termination. Plaintiff's complaint alleges $85,000 in back salary, performance bonus and a 40,000 share grant. Management intends to vigorously defend the action and contends the suit is without merit as the contractor was dismissed for cause. Accordingly, management has not provided a contingency reserve for this matter.

·

On June 13, 2011, we filed an action in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for the rescission of an investor relations and consulting agreement entered into on or about October 15, 2010 whereby we paid a third party approximately $20,000 and 23,000 shares of restricted common stock in consideration of investor relations and consulting services. We have demanded return of the 23,000 shares of restricted stock and recovery of costs and other damages. The third party has filed a counter claim for breach of the agreement. We intend to continue vigorously defend this claim.

·

During 2011, we also filed an action in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for the rescission of an agreement entered into on or about May 18, 2010 whereby we paid a third party approximately $500 and 20,000 shares of restricted common stock in consideration of consulting services. We have demanded return of the 20,000 shares of restricted stock and recovery of costs and other damages. The claim was dismissed for lack of jurisdiction and we re-filed the action in the Supreme Court, New York County, New York on or about January 11, 2012, seeking rescission of said agreement and the return of $500 and 20,000 shares of restricted common stock (See Note 21).

From time to time, the Company may be involved in various claims and legal actions arising from the ordinary course of business.  In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company's consolidated financial position or results of operations.

Purchase commitments

In order to secure an adequate supply of raw materials, the Company executes purchase orders to its suppliers as evidence of its intent to purchase materials. Purchase orders outstanding at December 31, 2013 totaled $685,137.

Contract contingencies

Our distribution agreement with Gamma Investors, a shareholder of the Company, provides that in the event we terminate the agreement without cause, we are required to repurchase all products held in Gamma's inventory and pay Gamma a fee equal to the greater of the prior 12 month product purchased by Gamma or $2 million. Transactions with Gamma have been de minimus to date.

Employment Agreement

Effective December 16, 2013, the Company entered into an executive employment agreement with Daniel Khesin, its current chief executive officer, to serve as chief executive officer, for an initial term through December 31, 2018 (the "Initial Term") and thereafter automatically renewed for successive one year terms (each, a "Renewal Term"), unless terminated upon six months prior written notice (a "Non Renewal Notice"). During the Initial Term his base salary shall be $250,000 and shall increase by 20% for any one quarterly period following a quarterly period in which the Company is profitable. Such increases do not accumulate or carry over to subsequent periods. The base salary, commencing year ending December 31, 2014 and subject to Nasdaq Rules, includes $50,000 payable in Company common stock valued at the closing price at the end of each calendar year during the term of the agreement. Furthermore, Mr. Khesin shall be entitled to receive an annual performance bonus, payable in stock and/or cash, based on achieving annual targets set by the board of directors.  Under the agreement Mr. Khesin shall be entitled to receive reimbursement for all reasonable travel, entertainment and miscellaneous expenses incurred in connection with the performance of his duties. Mr. Khesin is entitled to paid vacation as determined by the board and initially four weeks per annum. He is also entitled to participate in any pension, insurance or other employment benefit plan as maintained by the Company for its executives, including programs of life and medical insurance. The Company has agreed to maintain disability insurance and directors and officers' liability coverage during his employment term. In the event the Company fails to maintain a disability policy for Mr. Khesin and Mr. Khesin becomes disabled during the term of the agreement, then he shall continue to receive 25% of his base salary for a period of 10 years, or until the disability is removed.

If the Company terminates Mr. Khesin's employment without cause the Company shall pay as severance pay to Mr. Khesin within 30 days following the termination date, a lump sum amount equal to 42 months of his annual base salary and all of his options, if any, shall automatically vest and become fully exercisable.  Furthermore, upon delivery of a Non Renewal Notice, the Company shall also pay Mr. Khesin a lump sum amount equal to 42 months of his annual base salary. During the term of the agreement and for a 6 month period following the termination of the agreement, Mr. Khesin shall be subject to a non competition and non solicitation restrictions, unless his employment is terminated without cause by the Company or upon change of control of the Company or following a Non Renewal Notice.

EQUITY

EQUITY	12 Months Ended
	Dec. 31, 2013
EQUITY [Abstract]	'
EQUITY	'
	NOTE 13 - EQUITY
	Common Stock
	When shares are issued in lieu of cash for goods or services, such goods or services are valued based upon the shares issued multiplied by the closing price of the stock on the date immediately preceding such issuance.
	During the first quarter of 2012, the Company issued 28,182 shares for services provided by two employees valued at $3.10 - $3.20 per share, which resulted in an expense of $89,182 in aggregate. The Company also issued 8,824 shares as an award for achieving business goals. The shares were valued at $3.40, which resulted in an allowance offsetting revenues of $30,000.
	During the second quarter of 2012, the Company issued 108,764 shares for services provided by six associates valued at $2.00 - $2.80 per share, which resulted in an expense of $241,528 in aggregate. The Company also issued 38,514 shares as an award for achieving business goals at $2.60, which resulted in an allowance offsetting revenues of $100,000. In addition, a consultant exercised vested options for 40,700 common shares for $4,070.
	During the third quarter of 2012, the Company issued 28,000 shares for services provided by an IR firm and a former associate valued at $2.20 - $3.20 per share, which resulted in an expense of $69,600 in aggregate. Also during the quarter, two founders converted 450,000 shares of preferred stock into 450,000 of common shares. The Company also issued 292,000 shares to existing shareholder investors at $2.50 per share or $732,000 from which $146,400 in fees were paid to the selling agent, resulting in net proceeds of $585,600 to the Company.
	During the fourth quarter of 2012, the Company issued 31,367 shares to a distributor for achieving sales goals valued at $3.32 per share, which resulted in a sales allowance of $104,138 in aggregate. In connection with our license of the Nutra Origin brand, we issued 15,385 shares valued at $3.25 per share, which resulted in an increase in our brand rights intangible asset of $50,000.
	During the first quarter of 2013, the Company issued 15,300 shares to a distributor for achieving sales goals valued at $2.50 per share, which resulted in a sales allowance of $38,250 in aggregate. We also issued 20,000 shares to an investor relations ("IR") firm for services valued at $2.20 per share or $44,000 in total. Our directors received 5,000 shares for services valued at $3.20 per share or $16,000.
	During the second quarter of 2013, the Company issued 11,765 shares to a distributor for achieving sales goals valued at $2.11 per share, which resulted in a sales allowance of $24,824 in aggregate. We also issued 80,000 shares to an IR firm for services valued at $1.75 per share or $140,000 in total. Our directors received 7,500 shares for services valued between $1.75 and $2.61 per share or $16,350.
	During the third quarter of 2013, the Company sold an aggregate of 381,192 shares to four private investors at prices ranging from $1.00 to $1.15 per share for a total of approximately $410,000.  Fees were paid to a third party on three of the four transactions resulting in issuance costs of $31,260.  The Company also issued 28,433 shares in aggregate, to several distributors for achieving sales goals valued at $1.50 average per share, which resulted in a sales allowance of $42,649 in aggregate. We also issued 52,700 shares in aggregate to four investor relations ("IR") firms for services valued at $1.76 average per share or $92,550 in total. We also issued 31,779 shares to two associates for services rendered valued at $1.66 average per share or $52,721 in total.
	During the fourth quarter of 2013, the Company sold an aggregate of 8,943 shares to a private investor at $1.12 per share for a total of $10,000.  No fees were paid to a third party on this transaction.
	Under a Securities Purchase Agreement dated December 24, 2013, as amended (the "Securities Purchase Agreement"), the Company also sold 1,965,000 shares under a private placement, to a series of investors under a Securities Purchase Agreement at $1.60 per share for a total of $3,144,000. Fees were paid to a registered broker-dealer and legal counsel resulting in issuance costs of $151,051. Under the Securities Purchase Agreement, the Company has agreed to restrict the issuance of shares of Common Stock or common stock equivalents for a period of approximately nine months from the closing date, subject to certain exceptions.  In addition, subject to certain exceptions, if during a period of twelve months from the closing date of the Securities Purchase Agreement, the Company issues additional shares of Common Stock or common stock equivalents (the "Additional Shares") at a purchase, exercise or conversion price less than $1.60 (such price subject to adjustment for splits, recapitalizations and reorganizations), then the Company shall issue additional shares of Common Stock to the purchasers so that the effective purchase price per share paid for the Common Stock shall be the same per share purchase, exercise or conversion price of the Additional Shares; provided, however, the Additional Shares, when aggregated with all issuances under the Securities Purchase Agreement, shall not exceed 19.99% of the issued and outstanding Common Stock of the Company immediately prior to the closing date of the Securities Purchase Agreement.
	We also issued 94,679 shares in aggregate to five individuals who perform services for the Company valued at prices ranging from $1.91 to $2.31 per share or $190,336 in total. On November 20, 2013, we also issued 15,000 shares to our directors for services rendered and to be rendered under independent director agreements, valued at $2.02 per share or $30,300 in total.
	In summary, the Company issued stock for various services valued at $687,980 and $478,448 in 2013 and 2012, respectively.
	Surrender of Common Stock
	During the third quarter of 2012, an IR firm surrendered 20,000 shares previously issued for services not fully earned and previously valued at $2.80 per share, which resulted in a return to equity of $56,000 in aggregate.
	During the fourth quarter of 2012, an IR firm returned 5,000 shares valued at $3.36 per share, which resulted in a recovery of $16,800.
	Warrants
	The following tables present the status of warrants outstanding at December 31, 2013 and December 31, 2012, respectively
		Warrants			Weighted-		Weighted-		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term (in years)
	Year Ended December 31, 2012
	Outstanding at January 1, 2012		253,893		$	4.67		4.21	$	-
	Issued		-			-				-
	Exercised		-			-
	Forfeited		-			-
	Outstanding at December 31, 2012		253,893		$	4.67		3.21	$	-
	Exercisable at December 31, 2012		253,893		$	4.67		3.21	$	-
	Year Ended December 31, 2013
	Outstanding at January 1, 2013		253,893		$	4.67		3.21	$	-
	Issued		-			-
	Exercised		-			-
	Forfeited		-			-
	Outstanding at December 31, 2013		253,893		$	4.67		2.22	$	-
	Exercisable at December 31, 2013		253,893		$	4.67		2.22	$	-
	Options
	During 2009, the Company granted a selling agent an option to purchase 200,000 shares of common stock at an exercise price of $0.10 per share in exchange for his assistance in filing a registration statement on Form 10 and obtaining a trading symbol on the Over the Counter Bulletin Board (OTCBB). The option was valued at grant date based on the offering price $2.50 per share, which was $480,000 and expires in five years. The option vests and is exercisable subject to certain lock up and leak out provisions which limit exercisability of the option number to 20,000 shares per quarter. The Company obtained its trading symbol and recorded an expense for consulting services of $160,000 in 2010, $192,000 in 2011 and $128,000 in 2012 as a result of the structured vesting. At December 31, 2012 the options were fully expensed.  As of December 31, 2013, the Company had an equity incentive plan (See Note 15).  All options that have been granted through December 31, 2013 have been granted outside this plan.
	The following tables present the status of all options outstanding at December 31, 2013 and 2012:
		Options			Weighted-		Weighted-		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term (in years)
	Year Ended December 31, 2012
	Outstanding at January 1, 2012		73,333		$	0.1		3	$	264,000
	Issued		-			-
	Exercised		(40,700	)	$	0.1
	Forfeited		-			-
	Outstanding at December 31, 2012		32,633		$	0.1		2.16	$	107,690
	Exercisable at December 31, 2012		32,633		$	0.1		2.16	$	107,690
	Year Ended December 31, 2013
	Outstanding at January 1, 2013		32,633		$	0.1		2.16	$	107,690
	Issued		-			-
	Exercised		-		$	-
	Forfeited		-			-
	Outstanding at December 31, 2013		32,633		$	0.1		1.16	$	76,688
	Exercisable at December 31, 2013		32,633		$	0.1		1.16	$	76,688
	Preferred Stock
	As provided under Certificate of Designation for Series A Preferred Stock dated January 14, 2009, amended in September 2009, each share of Series A Preferred Stock is entitled to 0.2 votes per share and the Series A Preferred Stock votes together with the Company's common stock, except as otherwise provided under Florida law. The preferred stock automatically converts into common stock on a ten-to-one basis in September 2013. Two of the founders converted 4,500,000 preferred shares into 450,000 common shares during 2012. The remaining 5,500,000 shares were held by the remaining founder and CEO of the Company and converted into 550,000 common shares on September 15, 2013.

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2013
INCOME TAXES [Abstract]	'
INCOME TAXES	'
	NOTE 14. - INCOME TAXES
	The provision for income taxes for 2013-YTD and 2012-YTD is summarized as follows:
		2013				2012
	Current:
	Federal	$	-			$	-
	State		-				-
	Non-U.S.		-				-
			-				-
	Deferred:
	Federal		(906,445	)			(1,259,260	)
	State		(91,319	)			(95,418	)
	Non-U.S.		(17,109	)			(854	)
	Increase in valuation allowance		1,014,873				1,355,532
	Total provision (benefit) for income taxes	$	-			$	-
	The income tax benefit for 2013-YTD and 2012-YTD was not booked due to the uncertainty of future profitable operations necessary to realize the benefit.
	The provision for income taxes for 2013-YTD and 2012-YTD differs from the amount computed by applying the federal statutory rate to loss before provision (benefit) for income taxes as follows:
		2013			2012
	Expected provision (benefit) at statutory rate		(35.0%	)		(35.0%	)
	State taxes		(3.6%	)		(3.6%	)
	Non-U.S.		-%			-%
	Non-deductible expenses		-%			-%
	Increase in valuation allowance		38.60%			38.60%
	Total provision (benefit) for income taxes		-%			-%
	Deferred income taxes reflect the net tax effect of tax carry forward items and the temporary differences between the recognition of income and expenses for financial reporting purposes and for tax purposes. The tax effect of these temporary differences representing deferred tax assets and liabilities at December 31, 2013 and December 31, 2012 are as follows:
		2013				2012
	Deferred tax assets:
	Net operating loss carry-forwards	$	2,377,321			$	1,670,009
	Stock-based compensation		492,937				216,193
	Amortization		13,673				--
	Accrued interest		2,111				2,075
	Total deferred tax assets		2,886,042				1,888,277
	Valuation allowance		(2,886,042	)			(1,888,277	)
	Net deferred tax assets	$	-			$	-
	The valuation allowance increased $1,014,873 during 2013.
	As of December 31, 2013 and December 31, 2012, the Company had net operating loss carry-forwards of $5,165,561 and $4,329,251, respectively. Unused net operating loss carry-forwards will expire at various dates beginning in 2030 and ending on 2032. In accordance with Section 382 of the Internal Revenue code, the usage of the Company's net operating loss carryforward could be limited in the event of a change in ownership.
	As of December 31, 2013 and December 31, 2012, the Company had no unrecognized tax benefits and accordingly no related accrued interest or penalties.
	The Company follows the provisions of ASC Topic 740-10, "Accounting for Uncertainty in Income Taxes" which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements in accordance with ASC Topic 740, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
	Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our consolidated financial statements. Our evaluation was performed for the tax years ended December 31, 2013 and 2012. The Company's federal and state income tax returns since 2010 are subject to examination by the Internal Revenue Service, generally for a period of three years after the returns were filed.

2009_EQUITY_INCENTIVE_PLAN

2009 EQUITY INCENTIVE PLAN	12 Months Ended
	Dec. 31, 2013
2009 EQUITY INCENTIVE PLAN [Abstract]	'
2009 EQUITY INCENTIVE PLAN	'
	NOTE 15. - 2009 EQUITY INCENTIVE PLAN
	Overview - Options granted under the Company's 2009 Equity Incentive Plan (the "Plan") may be Incentive Stock Options or Nonstatutory Stock Options, as determined by the Administrator at the time of grant. Stock Purchase Rights, time vested and/or performance vested Restricted Stock, Stock Appreciation Rights and Unrestricted Shares may also be granted under the Plan.
	Subject to the Plan - The initial maximum number of shares of Common Stock that may be issued under the Plan is 500,000 shares. No more than 100,000 Shares of Common Stock may be granted to any one Participant with respect to Options, Stock Purchase Rights and Stock Appreciation Rights during any one calendar year period. Common Stock to be issued under the Plan may be either, authorized and unissued shares or shares held in treasury.
	Eligibility - Nonstatutory Stock Options, Stock Purchase Rights, Stock Awards, Stock Appreciation Rights and Unrestricted Shares may be granted to all Service Providers. Incentive Stock Options may be granted only to Employees.
	Limitations -  Each Option shall be designated as either an Incentive Stock Option or a Nonstatutory Stock Option. However, notwithstanding such designation, if an Employee becomes eligible in any given year to exercise Incentive Stock Options for Shares having a Fair Market Value in excess of $100,000, those Options representing the excess shall be treated as Nonstatutory Stock Options.
	Term - The term of each Option shall be stated in the applicable Option Agreement or, if not stated, ten years from the date of grant. However, in the case of an Incentive Stock Option granted to an Optionee who, at the time the Incentive Stock Option is granted, owns, directly or indirectly, stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company and any Parent or Subsidiary, the term of the Incentive Stock Option shall be five (5) years from the date of grant or such shorter term as may be provided in the applicable Option Agreement.
	Exercise and Vesting - Unless otherwise determined by the Administrator and provided for in the Option Agreement, each Option shall vest and become exercisable as to one-sixth (1/6) of the shares subject to the Option on the date that is nine months after the date of grant, and an additional one-sixth (1/6) of the shares subject to the Option every nine months thereafter until fully vested and exercisable.

SIGNIFICANT_CUSTOMERS

SIGNIFICANT CUSTOMERS	12 Months Ended
	Dec. 31, 2013
SIGNIFICANT CUSTOMERS [Abstract]	'
SIGNIFICANT CUSTOMERS	'
	NOTE 16. - SIGNIFICANT CUSTOMERS
	Our product revenues represent primarily sales of Revita and Revita Cor which individually exceed 10% of total sales and collectively represent 40% of total sales. Spectral DNC-N represents 9% of total sales. The Company sells its products to several types of customer, which primarily include distributors and salons, several of which represent individually in excess of 10% of total sales during 2013-YTD and 2012-YTD. During 2013-YTD our top ten customers generated 41% of our sales.
	There were no sales to customers individually in excess of 10% of total sales during 2013-YTD.
	Sales to customers individually in excess of 10% of total sales during 2012-YTD and their accounts receivable at December 31, 2012 were:
	Customer	Sales	Percent	Accounts	Percent
		Amount		Receivable
	B	$1,189,899	10%	$95,008	4%
	C	$1,470,277	13%	$459,875	18%

SIGNIFICANT_VENDORS

SIGNIFICANT VENDORS	12 Months Ended
	Dec. 31, 2013
SIGNIFICANT VENDORS [Abstract]	'
SIGNIFICANT VENDORS	'
	NOTE 17. - SIGNIFICANT VENDORS
	The Company purchases its raw materials from various foreign and domestic suppliers several of which represent individually in excess of 10% of total purchases. Purchases of raw materials consist primarily of basic chemicals and packaging materials. The Company believes that it enjoys cordial relationships with all its suppliers but should the need arise; the Company believes that it could transition to alternate suppliers with minimal adverse impact. It does not have any formal long term purchase agreements with its suppliers. The Company does issue purchase orders based on its production plan, which may be modified or cancelled should its production plan change.
	Purchases from significant vendors during 2013-YTD and their accounts payable at December 31, 2013 were:
	Vendor	Purchase	Percent	Accounts	Percent
		Amount		Payable
	A	$533,968	13%	$126,027	11%
	C	$764,357	19%	$  87,782	8%
	Purchases from significant venders during 2012-YTD and their accounts payable at December 31, 2012 were:
	Vendor	Purchase	Percent	Accounts	Percent
		Amount		Payable
	A	$1,074,456	19%	$  84,369	5%
	C	$   732,737	13%	$157,916	9%

GEOGRAPHIC_REVENUE_REPORTING

GEOGRAPHIC REVENUE REPORTING	12 Months Ended
	Dec. 31, 2013
GEOGRAPHIC REVENUE REPORTING [Abstract]	'
GEOGRAPHIC REVENUE REPORTING	'
	NOTE 18. - GEOGRAPHIC REVENUE REPORTING
	The Company is organized based on fundamentally one business segment although it does distribute its products on a world-wide basis. Several of its largest distributors are based in North America who in turn sell their products in Europe or Asia. We consider these customers as based in North America. However our sales to international distributors who distribute our product outside North America have been increasing. In 2012, we acquired our distributor in Mexico, the results of which are more fully discussed in Note 20.
	Information about the Company's geographic operations for both 2013-YTD and 2012-YTD as follows:
		2013		2012
	Net Revenue:
	North America	$	7,046,473	$	7,185,641
	International		6,605,188		4,038,783
		$	13,651,651	$	11,224,424
	Furniture and Equipment, Net:
	North America	$	112,456	$	169,859
	International		120,068		123,861
		$	232,524	$	293,720

CONSOLIDATION_OF_VARIABLE_INTE

CONSOLIDATION OF VARIABLE INTEREST ENTITY	12 Months Ended
	Dec. 31, 2013
CONSOLIDATION OF VARIABLE INTEREST ENTITY [Abstract]	'
CONSOLIDATION OF VARIABLE INTEREST ENTITY	'
	NOTE 19. - CONSOLIDATION OF VARIABLE INTEREST ENTITY
	The Company holds a variable interest in Velocity Storage and Packaging LLC ("Velocity") an entity for which the Company is the primary beneficiary. Velocity performs packaging and shipping services exclusively for the Company. The Company's variable interest relates to a financing arrangement whereby, all operational expenses including labor costs, facility costs and other operational expenses are reimbursed by the Company at Velocity's cost. The Company has no equity investment in Velocity and Velocity has no assets, liabilities or equity structure of its own. Accordingly, the Company determined that Velocity was a VIE and the Company was the primary beneficiary under the guidance offered in ASC 810-10 since Velocity does not have sufficient equity at risk for the entity to finance its own activities. ASC 810-10 requires that an enterprise consolidate a VIE if that enterprise has a variable interest that will absorb a majority of the entity's expected losses if they occur.

ACQUISITION_OF_MEXICAN_DISTRIB

ACQUISITION OF MEXICAN DISTRIBUTOR	12 Months Ended
	Dec. 31, 2013
ACQUISITION OF MEXICAN DISTRIBUTOR [Abstract]	'
ACQUISITION OF MEXICAN DISTRIBUTOR	'
	NOTE 20. - ACQUISITION OF MEXICAN DISTRIBUTOR
	Effective November 1, 2012, the Company purchased essentially 100% of the outstanding common stock of Divine Skin Laboratories, S.A. DE C.V. ("DS Mexico") from the sole shareholder pursuant to a Share Exchange Agreement. In accordance with Mexican law, Mexican companies must have two shareholders therefore the principal seller will retain one share of common stock of DS Mexico.
	DS Mexico is in the business of selling, distributing and marketing the Company's products throughout Mexico. The Company acquired DS Mexico in order to obtain customers and vertically integrate its operations directly in the Mexican market.
	In consideration for the nearly 100% interest in DS Mexico, the Company issued 450,000 shares of the Company's common stock valued at $2.60 per share, based on an independent third party valuation. The Company also forgave $38,415 of invoices due from DS Mexico between April 1, 2012 and September 30, 2012. Following the closing date the sole shareholder of DS Mexico shall receive up to an aggregate of an additional 150,000 shares of DSKX Common Stock (as adjusted for a stock split, recapitalization or similar transaction) as follows:
	(i)
	50,000 shares of DSKX Common Stock in the event that annual net revenues of DS Mexico are equal to or greater than $4,000,000 during any calendar year period;
	(ii)
	50,000 shares of DSKX Common Stock in the event annual net revenues of DS Mexico are equal to or greater than $5,000,000 during any calendar year period following satisfaction of (i); and
	(iii)
	50,000 shares of DSKX Common Stock in the event annual net revenues of DS Mexico are equal to or greater than $6,000,000 during any calendar year period following satisfaction of (ii).
	In connection with the Share Exchange Agreement, the Company issued 600,000 shares of its stock, of which 450,000 shares have been delivered as of December 31, 2012. The remaining 150,000 shares are held in escrow by the Company to be delivered upon completion of the performance measures as stipulated by the Share Exchange Agreement.  As of December 31, 2013 such shares remain in escrow.
	The present value of the consideration expected to be paid as part of this agreement is $1,341,015, as calculated below:
	·
	450,000 shares issued and valued at $2.60 per share, for a total of $1,170,000.
	·
	150,000 contingent shares valued at $2.60 per share, for a total of $132,600.
	·
	Forgiveness of $38,415 of invoices due from DS Mexico.
	The price per share and the estimated contingent shares to be issued in connection with this agreement were based upon a third party valuation.
	The Company incurred approximately $5,000 in professional fees in connection with its acquisition of DS Mexico in 2012.
	The following summarizes the fair value of the assets and liabilities acquired:
	Cash	$	127,321
	Accounts receivable		380,522
	Inventory		159,379
	Prepaid and other current assets		87,125
	Property and equipment, net		126,628
	Customer list		932,000
	Goodwill		34,444
	Accounts payable		(455,726	)
	Other current liabilities		(50,678	)
	Total net assets acquired	$	1,341,015
	Aggregate purchase price	$	1,341,015
	Dr. Tamez, the former principal shareholder of DS Mexico, has agreed to oversee the day to day operations of DS Mexico in consideration of a base salary of approximately $60,000 per year. In further consideration of his employment with DS Mexico, we and Dr. Tamez entered into a performance agreement dated December 11, 2012, whereby Dr. Tamez shall receive on each 12 month anniversary of the agreement, and each year thereafter for a period of five years, such number of shares of our common stock that shall have a cumulative value of $50,000. Furthermore, during the term of Dr. Tamez's employment he shall be entitled, on a calendar year basis, to 30% of the net profits of DS Mexico (the "Profit Participation"). Commencing on the third calendar anniversary of the performance agreement with us, we shall have the option of terminating the Profit Participation in consideration of a $500,000 payment to Dr. Tamez. Furthermore, in the event that a "Change of Control" of us during the term of Dr. Tamez's employment with us, Dr. Tamez shall have the right to receive a one-time payment of $500,000. A "Change of Control" of us shall be deemed to have occurred at such time as: (1) any person (as such term is used in Section 13(d) and 14(d) of the Exchange Act) is or becomes the "beneficial owner" (as defined in Rule 13d-3 under the Exchange Act, directly or indirectly, of our securities representing 80% or more of the combined voting power of our outstanding securities then having the right to vote at elections of directors; (2) any person becomes the beneficial owner, directly or indirectly of, either: (i) 50% of DS Mexico's outstanding shares or (ii) 30% of DS Mexico´s shares, within a period of one year; (3) the board of directors of DS Mexico, currently consisting of Daniel Khesin, Michael Strong and Fernando Tamez, is changed in its majority; or (d) 40% of the gross value of DS Mexico´s assets is transferred to an unrelated party.
	The following unaudited pro forma financial information presents the combined results of operations for the year ended December 31, 2012 as if the acquisition had been completed as of January 1, 2012. The pro forma financial information includes adjustments to eliminate one time charges in the appropriate pro forma periods as though the acquisition had been completed at the beginning of the respective periods, and is not indicative of, nor does it purport to project the future financial position or operating results of the company.
	The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may be implemented after the acquisition.
		For the
		Year Ended
		December 31,
		2012
	Revenue	$	12,398,592
	Net Income (Loss) Attributable to Shareholders of DS Healthcare Group, Inc	$	-3,623,773
	Net (loss) income per common share:
	Basic and diluted	$	-0.03
	Weighted average shares outstanding:
	Basic and diluted		11,507,784

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2013
SUBSEQUENT EVENTS [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 21. - SUBSEQUENT EVENTS
	Debt Financing -
	Effective March 24, 2014, the Company's asset based lending facility with MidCap Financial was renewed for three months and now matures on June 30, 2014.  The terms of the renewal provides for asset based lending collateralized by all assets of the Company. Advances are based on 70% of qualified accounts receivable and 40% of eligible finished goods inventory. The credit facility provides for interest and bank fees, which currently aggregate to 8% (prime plus 3% plus 1.75% asset monitoring fees and other fees) per annum. The overall facility has been reduced to $1.0 million.  The credit facility is personally guaranteed by our Chief Executive Officer (See Note 11).
	Pending and threatened litigation -
	As disclosed under Note 12, during 2011, we filed an action in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for the rescission of an agreement entered into on or about May 18, 2010 whereby we paid a third party approximately $500 and 20,000 shares of restricted common stock in consideration of consulting services. We had demanded return of the 20,000 shares of restricted stock and recovery of costs and other damages. The claim was dismissed for lack of jurisdiction and we re-filed the action in the Supreme Court, New York County, New York on or about January 11, 2012, seeking rescission of said agreement and the return of $500 and 20,000 shares of restricted common stock.  During March 2014, the matter was settled and each party released the other from all claims related to the action.  Under a settlement matter and general release, the defendant agreed to return to Company treasury 10,000 shares common stock subject to the dispute, and of the remaining 10,000 shares, the defendant agreed to a one year lock up agreement covering 60% of the shares for a period of one year from the settlement date.
	Equity -
	Subsequent to December 31, 2013, the Company issued 221,000 shares in aggregate to four individuals who perform services for the Company valued at prices ranging from $2.20 to $2.44 per share or $494,595 in total. We also issued 3,750 shares to our directors for services rendered and to be rendered under independent director agreements, valued at $2.22 per share or $8,325 in total.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)	12 Months Ended
	Dec. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Principles of Consolidation and Presentation	'
	Principles of Consolidation and Presentation
	The consolidated financial statements are prepared using the accrual basis of accounting where revenues and expenses are recognized in the period in which they were incurred. The basis of accounting conforms to accounting principles generally accepted in the United States of America.
	The consolidated financial statements include the accounts of the Company and its operating subsidiaries DS Laboratories, Inc., Sigma Development and Holding Co., Inc., Polaris Labs, Inc., Nutra Origin, Inc. and Divine Skin Laboratories, S.A. de CV. Also included in the consolidated financial statements are the operating activities of Velocity Storage and Packaging, LLC and Wally Group, LLC an inactive entity, which are accounted for as VIEs. All significant intercompany balances and transactions have been eliminated in consolidation.
Prior Period Reclassifications	'
	Prior Period Reclassifications
	Certain prior period amounts that were combined in the December 31, 2012 consolidated financial statements have been reclassified for comparability with the December 31, 2013 presentation. These reclassifications had no effect on previously reported net loss.
Use of Estimates	'
	Use of Estimates
	The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. We believe our estimates and assumptions are reasonable; however, such estimates and assumptions are subject to a number of risks and uncertainties that may cause actual results to differ materially from such estimates. Significant estimates and assumptions underlying these consolidated financial statements include:
	·	Estimates of allowances for uncollectable accounts receivable,
	·	Estimates of inventory obsolescence and overhead and labor cost allocations,
	·	Estimates assuming future earning capacity of our intangible assets,
	·	Estimates of value of equity transactions for services rendered,
	·	Estimates of returned or damaged product, and
	·	Estimates made in our deferred income tax calculations.
Risks and Uncertainties	'
	Risks and Uncertainties
	The Company's business could be impacted by price pressure on its product manufacturing, acceptance of its products in the market place, new competitors, changes in federal and/or state legislation and other factors. The Company also has been experiencing significant growth which puts serious strains on its cash availability requirements. If the Company is unsuccessful in securing adequate liquidity, its plans may be curtailed. Adverse changes in these areas could negatively impact the Company's financial position, results of operations and cash flows.
Business Acquisitions	'
	Business Acquisitions
	Acquired businesses are accounted for using the acquisition method of accounting. The acquisition method of accounting for acquired businesses requires, among other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date. The excess of the purchase price over the assigned values of the net assets acquired, if any, is recorded as goodwill. Transaction costs are expensed as incurred.
Cash	'
	Cash
	The Company maintains its cash and cash equivalents in financial institutions located in the United States. At times, the Company's cash and cash equivalent balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limits. The Company has not experienced any losses in such accounts.
Accounts Receivable	'
	Accounts Receivable
	Accounts receivable are reported at their net realizable value. The Company establishes an allowance for doubtful accounts based upon factors pertaining to the credit risk of specific customers, historical trends, and other information. Delinquent accounts are written-off when it is determined that the amounts are uncollectible. The Company also provides for allowances against accounts receivables for product returns and cooperative advertising allowances. At December 31, 2013 and 2012, the allowance for uncollectable accounts was $305,314 and $373,981, respectively, $210,000 and $110,000 respectively for defectives and product returns and $60,000 at both dates for advertising credits.
Inventory	'
	Inventory
	Inventory is reported at the lower of cost or market on the FIFO method. Our inventory is subject to expiration and obsolescence. Accordingly, quantities purchased and sell through rates are periodically monitored for potential overstocking or pending expiration as a basis for establishing the appropriate reserve for any estimated expiration or obsolescence.
Furniture and Equipment	'
	Furniture and Equipment
	Furniture and equipment are recorded at cost and depreciation is provided using the double declining balance depreciation method in the United States and the straight line depreciation method in Mexico over the estimated useful lives of the assets, which range from 5 to 7 years. The Company recorded $111,919 and $46,678 in depreciation expense during 2013-YTD and 2012-YTD, respectively. Accumulated depreciation was $238,051 and $101,972 at December 31, 2013 and 2012, respectively. Expenditures for repairs and maintenance of equipment are charged to expense as incurred. Major replacements and betterments are capitalized and depreciated over the remaining useful lives of the assets.
Long-Lived Assets	'
	Long-Lived Assets
	Long-lived assets and certain identifiable intangibles held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period. The Company evaluates the recoverability of long-lived assets based upon forecasted undiscounted cash flows. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted, based on estimates of future discounted cash flows resulting from the use and ultimate disposition of the asset.  Assets disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.
Intangible Assets	'
	Intangible Assets
	Intangible assets acquired individually, with a group of other assets, or in a business combination, are recorded at fair value. The Company's identifiable intangible assets consist of customer relationships acquired as part of the Merger. The fair value of intangible assets acquired was determined based on a discounted cash flow analysis. Identifiable intangible assets are being amortized over the period of estimated benefit using the straight-line method, which approximates the customer attrition rate, reflecting the pattern of economic benefits associated with these assets, and have estimated useful lives between 6 and 10 years.
Goodwill	'
	Goodwill
	The Company records goodwill when the purchase price of an acquisition exceeds the fair value of the net tangible and intangible assets as of the date of acquisition. The Company performs an annual review of goodwill for indicators of impairment. When it is determined that goodwill may be impaired, the Company performs an impairment assessment of the acquired reporting unit and impairment tests using a fair value approach. As of December 31, 2013, the Company has not identified any such impairment.
Non-Controlling Interest	'
	Non-Controlling Interest
	Non-controlling interest consists of the minority owned portion of Nutra Origin, Inc. During the fourth quarter of 2012, the Company completed its license of the Nutra Origin brand. In addition, the Company established a new subsidiary to operate the Nutra Origin brand. As part of the license agreement, the licensor was granted a 7% non-controlling interest in the newly formed subsidiary.  The Company is currently in default of its license agreement for non-payment and has fully impaired related brand rights of $89,705.
Revenue Recognition	'
	Revenue Recognition
	Revenue is recognized when a product is shipped and risk of loss is transferred. The Company manages the collection process for transactions processed on its website, but it outsources its fulfillment (delivery) process to third parties.  The Company's revenue recognition policies are in compliance with ASC Topic 605, "Revenue Recognition", which establishes criteria that must be satisfied before revenue is realized or realizable and earned. The Company recognizes revenue when all of the following four criteria are met:
	·	persuasive evidence of a sales arrangement exists,
	·	delivery has occurred,
	·	the sales price is fixed or determinable and
	·	collectability is probable.
	Shipping and handling charges related to sales transactions are recorded as sales revenues when billed to customers or included in the sales price.  Shipping and handling costs are included in cost of goods sold.
Research and Development	'
	Research and Development
	The Company currently maintains a functional laboratory employing two full time chemists, a part time chemist/consultant and a lab technician that identify new technology, test product alternatives and improve existing formulations. In addition, our founder and CEO devotes a substantial portion of his time in identifying new technologies and formulations to develop new products and improve existing products with the newest technology available. Such activities are expensed in the year incurred. Such costs include laboratory supplies, salaries, materials and consultant fees. These costs are classified as product development, salaries, selling, general and administrative expenses in the consolidated statements of operations, and amounted to $170,451 and $196,108 for 2013-YTD and 2012-YTD, respectively.
Share-Based Payment	'
	Share-Based Payment
	The Company measures compensation cost for all employee stock-based awards at their fair values on the date of grant. Stock-based awards issued to non-employees are measured at their fair values on the date of grant, and are re-measured at each reporting period through their vesting dates. When a non-employee becomes an employee and continues to vest in the award, the fair value of the individual's award is re-measured on the date that he becomes an employee, and then is not subsequently re-measured at future reporting dates. The fair value of stock based awards is recognized as expense over the service period, net of estimated forfeitures, using the straight-line method for stock options and restricted stock. The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock-based awards.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. A valuation allowance is recorded when it is more likely than not that some portion or all of a deferred tax asset will not be realized,  At December 31, 2013 and 2012, a full valuation allowance was provided against our deferred tax assets.  Income tax expense is the result of Mexican operations.
Earnings per share	'
	Earnings per share
	The Company computes basic and diluted earnings per share amounts in accordance with ASC Topic 260, "Earnings per Share". Basic earnings per share is computed by dividing net income (loss) attributable to shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company. Vested warrants for 253,893 shares and vested options for 32,633 shares were excluded from the earnings per share calculation because they would be anti-dilutive.
Segment Information	'
	Segment Information
	ASC Topic 280, "Disclosures about Segments of an Enterprise and Related Information," established standards for the way that public business enterprises report information about operating segments in annual financial statements and requires those enterprises to report selected information about operating segments in interim financial reports issued to stockholders. Management has determined that the Company operates in one business segment, which is the commercialization and development of personal care products.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	Fair value is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. We currently do not have any financial assets and liabilities that are recurring that would require us to disclose them at fair value.
Subsequent Events	'
	Subsequent Events
	Management has evaluated subsequent events or transactions occurring through the date the financial statements were issued. Management concluded that no additional subsequent events required disclosure in these financial statements other than those disclosed in these notes to these financial statements.
Functional Currency	'
	Functional Currency
	The U.S. dollar is the functional currency of our consolidated entities operating in the United States. The functional currency for our consolidated entity operating outside of the United States is the Mexican peso. We translate their financial statements into U.S. dollars as follows:
	·	Assets and liabilities are translated at the exchange rate in effect as of the financial statement date.
	·	Income statement accounts are translated using the weighted average exchange rate for the period.
	We include translation adjustments from currency exchange and the effect of exchange rate changes on intercompany transactions of a long-term investment nature as a separate component of shareholders' equity. There are currently no transactions of a long-term investment nature, nor any gains or losses from non-U.S. currency transactions.

INVENTORY_Tables

INVENTORY (Tables)	12 Months Ended
	Dec. 31, 2013
INVENTORY [Abstract]	'
Schedule of the Significant Components of Inventory	'
	Significant components of inventory at December 31, 2013 and December 31, 2012 consist primarily of:
		2013			2012
	Bulk product and raw materials	$	1,930,848		$	2,402,331
	Work in process		192,319			237,284
	Merchandise inventory		965,127			1,074,833
	Inventory in transit		164,005			239,502
	Less: Allowance		(549,720	)		(500,000	)
		$	2,702,579		$	3,453,950

PREPAID_EXPENSES_AND_OTHER_CUR1

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)	12 Months Ended
	Dec. 31, 2013
PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]	'
Schedule of Prepaid Expenses and Other Current Assets	'
	Prepaid expenses and other current assets at December 31, 2013 and December 31, 2012 consist primarily of:
		2013		2012
	Prepaid rent	$	28,620	$	21,200
	Prepaid insurance		38,523		24,304
	Deferred financing costs, net of amortization		4,688		61,828
	Prepaid value added tax		12,059		30,228
	Employee advances		11,500		-
	Other receivables		126,126		-
	Prepaid board fees		15,150		-
	Pending VAT and other advances		53,219		21,604
		$	289,885	$	159,164

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2013
INTANGIBLE ASSETS [Abstract]	'
Schedule of Intangible Assets	'
	Significant components of intangible assets at December 31, 2013 and December 31, 2012 consist of:
		2013			2012
	Distribution rights in Brazil	$	750,000		$	750,000
	Less: Accumulated amortization		(318,750	)		(243,750	)
	Net distribution rights		431,250			506,250
	Pure Guild brand rights		159,086			159,086
	Less: Accumulated amortization		(92,570	)		(77,790	)
	Net brand right		66,516			81,296
	Nutra Origin license		-			144,307
	Less: Accumulated amortization		-			(6,500	)
	Net license		-			137,807
	DS Mexico Customer list		932,000			932,000
	Less: Accumulated amortization		(119,662	)		(16,945	)
	Net customer list		812,338			915,055
	Goodwill		36,285			34,444
		$	1,346,389		$	1,674,852
Schedule of Future Amortization Expense for Intangible Assets	'
	The following table represents the amortized cost of the various assets over the remaining years, the weighted average remaining period is 6.99 years.
		2014			2015			2016		2017		Beyond		Total
	Asset:
	Brazil distribution rights	$	75,000		$	75,000		$	75,000	$	75,000	$	131,250	$	431,250
	Pure Guild brand rights		14,780			14,780			14,780		14,780		7,396		66,516
	Mexican Customer list		103,500			103,500			103,500		103,500		398,338		812,338
		$	193,280		$	193,280		$	193,280	$	193,280	$	536,984	$	1,310,104

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	12 Months Ended
	Dec. 31, 2013
ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]	'
Schedule of Accounts Payable and Accrued Expenses	'
	Accrued expenses at December 31, 2013 and December 31, 2012 consist of:
		2013		2012
	Accrued expenses:
	Advertising and marketing	$	12,264	$	60,264
	Commissions		261,151		362,346
	Director services		18,750		---
	Facilities		12,535		38,023
	Fees / interest		21,003		19,012
	Investor relations		390,703		44,000
	Production materials		144,543		-
	Other		-		61,807
	Personnel		70,000		109,930
	Professional fees		15,000		9,500
		$	945,949	$	704,882

OTHER_CURRENT_LIABILITIES_Tabl

OTHER CURRENT LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2013
OTHER CURRENT LIABILITIES [Abstract]	'
Schedule of Other Current Liabilities	'
	Other current liabilities at December 31, 2013 and December 31, 2012 consist of:
		2013		2012
	Customer deposits	$	29,959	$	22,689
	Credit cards		47,597		117,006
	VAT Taxes payable		142,848		78,989
	Current portion of long term debt		10,770		8,723
	Insurance premium financing		4,770		-
	Vendor financing		50,338		-
		$	286,282	$	227,407

DEBT_FINANCING_Tables

DEBT FINANCING (Tables)	12 Months Ended
	Dec. 31, 2013
DEBT FINANCING [Abstract]	'
Schedule of Long-Term Debt	'
	Principal payout over the life of the loan is as follows:
		2014		2015		2016		2017		Total
	Long Term Debt	$	10,770	$	11,429	$	12,127	$	12,869	$	47,195

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2013
COMMITMENTS AND CONTINGENCIES [Abstract]	'
Schedule of Future Minimum Operating Lease Payments	'
	The Company is committed to lease payments over the next five years are as follows:
		2014		2015		2016		Beyond		Total
	Facility Leases:
	Deerfield Beach, Florida (Production) (HQ)	$	189,000	$	-	$	-	$	-	$	189,000
	Ashville, North Carolina (Sales)		56,695		56,695		-		-		113,390
		$	245,695	$	56,695	$	-	$	-	$	302,390

EQUITY_Tables

EQUITY (Tables)	12 Months Ended
	Dec. 31, 2013
EQUITY [Abstract]	'
Schedule of Outstanding Warrant Activity	'
	The following tables present the status of warrants outstanding at December 31, 2013 and December 31, 2012, respectively
		Warrants			Weighted-		Weighted-		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term (in years)
	Year Ended December 31, 2012
	Outstanding at January 1, 2012		253,893		$	4.67		4.21	$	-
	Issued		-			-				-
	Exercised		-			-
	Forfeited		-			-
	Outstanding at December 31, 2012		253,893		$	4.67		3.21	$	-
	Exercisable at December 31, 2012		253,893		$	4.67		3.21	$	-
	Year Ended December 31, 2013
	Outstanding at January 1, 2013		253,893		$	4.67		3.21	$	-
	Issued		-			-
	Exercised		-			-
	Forfeited		-			-
	Outstanding at December 31, 2013		253,893		$	4.67		2.22	$	-
	Exercisable at December 31, 2013		253,893		$	4.67		2.22	$	-
Schedule of Outstanding Stock Option Activity	'
	The following tables present the status of all options outstanding at December 31, 2013 and 2012:
		Options			Weighted-		Weighted-		Aggregate
					Average		Average		Intrinsic
					Exercise		Remaining		Value
					Price		Contractual
							Term (in years)
	Year Ended December 31, 2012
	Outstanding at January 1, 2012		73,333		$	0.1		3	$	264,000
	Issued		-			-
	Exercised		(40,700	)	$	0.1
	Forfeited		-			-
	Outstanding at December 31, 2012		32,633		$	0.1		2.16	$	107,690
	Exercisable at December 31, 2012		32,633		$	0.1		2.16	$	107,690
	Year Ended December 31, 2013
	Outstanding at January 1, 2013		32,633		$	0.1		2.16	$	107,690
	Issued		-			-
	Exercised		-		$	-
	Forfeited		-			-
	Outstanding at December 31, 2013		32,633		$	0.1		1.16	$	76,688
	Exercisable at December 31, 2013		32,633		$	0.1		1.16	$	76,688

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2013
INCOME TAXES [Abstract]	'
Schedule of Provision of Income Taxes	'
	The provision for income taxes for 2013-YTD and 2012-YTD is summarized as follows:
		2013				2012
	Current:
	Federal	$	-			$	-
	State		-				-
	Non-U.S.		-				-
			-				-
	Deferred:
	Federal		(906,445	)			(1,259,260	)
	State		(91,319	)			(95,418	)
	Non-U.S.		(17,109	)			(854	)
	Increase in valuation allowance		1,014,873				1,355,532
	Total provision (benefit) for income taxes	$	-			$	-
Reconciliation of the U.S. Federal Statutory Tax Rate to the Company's Effective Income Tax Rate	'
	The provision for income taxes for 2013-YTD and 2012-YTD differs from the amount computed by applying the federal statutory rate to loss before provision (benefit) for income taxes as follows:
		2013			2012
	Expected provision (benefit) at statutory rate		(35.0%	)		(35.0%	)
	State taxes		(3.6%	)		(3.6%	)
	Non-U.S.		-%			-%
	Non-deductible expenses		-%			-%
	Increase in valuation allowance		38.60%			38.60%
	Total provision (benefit) for income taxes		-%			-%
Schedule of Deferred Tax Assets	'
	The tax effect of these temporary differences representing deferred tax assets and liabilities at December 31, 2013 and December 31, 2012 are as follows:
		2013				2012
	Deferred tax assets:
	Net operating loss carry-forwards	$	2,377,321			$	1,670,009
	Stock-based compensation		492,937				216,193
	Amortization		13,673				-
	Accrued interest		2,111				2,075
	Total deferred tax assets		2,886,042				1,888,277
	Valuation allowance		(2,886,042	)			(1,888,277	)
	Net deferred tax assets	$	-			$	-

SIGNIFICANT_CUSTOMERS_Tables

SIGNIFICANT CUSTOMERS (Tables)	12 Months Ended
	Dec. 31, 2013
SIGNIFICANT CUSTOMERS [Abstract]	'
Schedule of Sales to Significant Customers	'
	Sales to customers individually in excess of 10% of total sales during 2012-YTD and their accounts receivable at December 31, 2012 were:
	Customer	Sales	Percent	Accounts	Percent
		Amount		Receivable
	B	$1,189,899	10%	$95,008	4%
	C	$1,470,277	13%	$459,875	18%

SIGNIFICANT_VENDORS_Tables

SIGNIFICANT VENDORS (Tables)	12 Months Ended
	Dec. 31, 2013
SIGNIFICANT VENDORS [Abstract]	'
Schedule of Significant Purchases from Vendors	'
	Purchases from significant vendors during 2013-YTD and their accounts payable at December 31, 2013 were:
	Vendor	Purchase	Percent	Accounts	Percent
		Amount		Payable
	A	$533,968	13%	$126,027	11%
	C	$764,357	19%	$  87,782	8%
	Purchases from significant venders during 2012-YTD and their accounts payable at December 31, 2012 were:
	Vendor	Purchase	Percent	Accounts	Percent
		Amount		Payable
	A	$1,074,456	19%	$  84,369	5%
	C	$   732,737	13%	$157,916	9%

GEOGRAPHIC_REVENUE_REPORTING_T

GEOGRAPHIC REVENUE REPORTING (Tables)	12 Months Ended
	Dec. 31, 2013
GEOGRAPHIC REVENUE REPORTING [Abstract]	'
Schedule of Revenues by Geographic Area	'
	Information about the Company's geographic operations for both 2013-YTD and 2012-YTD as follows:
		2013		2012
	Net Revenue:
	North America	$	7,046,473	$	7,185,641
	International		6,605,188		4,038,783
		$	13,651,651	$	11,224,424
	Furniture and Equipment, Net:
	North America	$	112,456	$	169,859
	International		120,068		123,861
		$	232,524	$	293,720

ACQUISITION_OF_MEXICAN_DISTRIB1

ACQUISITION OF MEXICAN DISTRIBUTOR (Tables)	12 Months Ended
	Dec. 31, 2013
Schedule of Purchase Price Allocation	'
	The following summarizes the fair value of the assets and liabilities acquired:
	Cash	$	127,321
	Accounts receivable		380,522
	Inventory		159,379
	Prepaid and other current assets		87,125
	Property and equipment, net		126,628
	Customer list		932,000
	Goodwill		34,444
	Accounts payable		(455,726	)
	Other current liabilities		(50,678	)
	Total net assets acquired	$	1,341,015
	Aggregate purchase price	$	1,341,015
Schedule of Pro Forma Financial Information	'
	The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may be implemented after the acquisition.
		For the
		Year Ended
		December 31,
		2012
	Revenue	$	12,398,592
	Net Income (Loss) Attributable to Shareholders of DS Healthcare Group, Inc	$	-3,623,773
	Net (loss) income per common share:
	Basic and diluted	$	-0.03
	Weighted average shares outstanding:
	Basic and diluted		11,507,784

ORGANIZATION_AND_NATURE_OF_BUS1

ORGANIZATION AND NATURE OF BUSINESS (Details) (USD $)	12 Months Ended		3 Months Ended		12 Months Ended
	Dec. 31, 2012	Dec. 31, 2013	Jun. 30, 2012	Jun. 30, 2012	Dec. 31, 2009
		Nutra Origin Inc. [Member]	Pure Guild Brand License [Member]	Nutra Origin License [Member]	DS Laboratories Brazil [Member]
Business Acquisition [Line Items]	'	'	'	'	'
Percentage of brand license acquired	'	'	100.00%	'	'
Monthly license fee	'	'	'	$7,500	'
Exclusive Agreement Period	'	'	'	'10 years	'10 years
Common stock issued for acquisition of assets	$50,000	'	'	$50,000	'
Business Combination, Separately Recognized Transactions [Line Items]	'	'	'	'	'
Interest in subsidiaries	'	7.00%	'	'	'
Stockholders Equity Note [Line Items]	'	'	'	'	'
Reverse stock split	'10:1	'	'	'	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Summary Of Significant Accounting Policies [Line Items]	'	'
Provision for doubtful accounts receivable	$305,314	$373,981
Product return and advertising reserve	210,000	110,000
Advertising credits	60,000	60,000
Depreciation expense	111,919	46,678
Accumulated depreciation	238,051	101,972
Contracted research and development expense	170,451	196,108
Minimum [Member]	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Property and equipment, estimated useful life	'5 years	'
Finite-Lived Intangible Asset, Useful Life	'6 years	'
Maximum [Member]	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Property and equipment, estimated useful life	'7 years	'
Finite-Lived Intangible Asset, Useful Life	'10 years	'
Stock Options [Member]	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Anti-dilutive shares from the earnings per share calculation	32,633	'
Warrant [Member]	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Anti-dilutive shares from the earnings per share calculation	253,893	'
Nutra Origin Inc. [Member]	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'
Interest in subsidiaries	7.00%	'
Impairment of Intangible Assets, Finite-lived	$89,705	'

LIQUIDITY_Details

LIQUIDITY (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
LIQUIDITY [Abstract]	'	'	'
Cash	$2,872,946	$412,488	$1,284,343
Accumulated deficit	$8,307,420	$5,097,990	'

INVENTORY_Details

INVENTORY (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
INVENTORY [Abstract]	'	'
Bulk product and raw materials	$1,930,848	$2,402,331
Work in process	192,319	237,284
Merchandise inventory	965,127	1,074,833
Inventory in transit	164,005	239,502
Less: Allowance	-549,720	-500,000
Inventory, net, total	2,702,579	3,453,950
Reserve for slow moving inventory	$549,720	$500,000

PREPAID_EXPENSES_AND_OTHER_CUR2

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]	'	'
Prepaid rent	$28,620	$21,200
Prepaid insurance	38,523	24,304
Deferred financing costs, net of amortization	4,688	61,828
Prepaid value added tax	12,059	30,228
Employee advances	11,500	'
Other receivables	126,126	'
Prepaid board fees	15,150	'
Pending VAT and other advances	53,219	21,604
Prepaid expenses and other current assets	289,885	159,164
Advance payments towards insurance	111,960	'
Amortization of prepaid insurance	77,264	'
Deferred issuance costs	18,750	'
Amortization of financing costs	$47,908	'

INTANGIBLE_ASSETS_Schedule_of_

INTANGIBLE ASSETS (Schedule of Intangible Assets) (Details) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2009

Dec. 31, 2013

Dec. 31, 2012

Jun. 30, 2012

Sep. 30, 2009

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Distribution Rights In Brazil [Member]

Distribution Rights In Brazil [Member]

Distribution Rights In Brazil [Member]

Pure Guild Brand Rights [Member]

Pure Guild Brand Rights [Member]

Pure Guild Brand Rights [Member]

Pure Guild Brand Rights [Member]

Nutra Origin License [Member]

Nutra Origin License [Member]

Mexican Customer list [Member]

Mexican Customer list [Member]

Finite-Lived Intangible Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Finite-lived intangible asset, gross

'

'

'

$750,000

$750,000

'

'

$159,086

$159,086

'

$144,307

$932,000

$932,000

Finite-lived intangible asset, accumulated amortization

'

'

'

-318,750

-243,750

'

'

-92,570

-77,790

'

-6,500

-119,662

-16,945

Finite-lived intangible assets, net, total

'

'

'

431,250

506,250

'

'

66,516

81,296

'

137,807

812,338

915,055

Goodwill

36,285

34,444

'

'

'

'

'

'

'

'

'

'

'

Total intangible assets

1,346,389

1,674,852

'

'

'

'

'

'

'

'

'

'

'

Purchase brand rights, shares

'

'

300,000

'

'

'

'

'

'

'

'

'

'

Per share value of stock issued for purchase of intangible asset

'

'

$2.50

'

'

'

'

'

'

'

'

'

'

Amortization expense related to intangible assets

'

'

'

'

'

'

'

14,780

20,190

48,102

'

101,670

16,945

Product exchanged for rights

'

'

'

'

'

'

106,666

'

'

'

'

'

'

Approximate percentage of initial stocking order

'

'

'

'

'

'

70.00%

'

'

'

'

'

'

Investment value in joint venture

'

'

'

75,000

75,000

'

'

'

'

'

'

'

'

Inventory

'

'

'

'

'

50,000

'

'

'

'

'

'

'

Amortization period of intangible asset

'

'

'10 years

'

'

'6 years

'5 years

'

'

'

'

'9 years

'

Weighted average remaining amortization period

'6 years 11 months 27 days

'

'

'

'

'

'

'

'

'

'

'

'

Monthly license fee

'

'

'

'

'

'

'

'

'

7,500

'

'

'

Exclusive agreement period

'

'

'10 years

'

'

'

'

'

'

'10 years

'

'

'

Purchase brand rights

'

50,000

'

'

'

'

'

'

'

50,000

'

'

'

Impairment of Intangible Assets, Finite-lived

'

'

'

'

'

'

'

'

'

$89,705

'

'

'

INTANGIBLE_ASSETS_Schedule_of_1

INTANGIBLE ASSETS (Schedule of Future Amortization Expense for Intangible Assets) (Details) (USD $)	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]	'
2014	$193,280
2015	193,280
2016	193,280
2017	193,280
Beyond	536,984
Amortized cost of assets	1,310,104
Brazil distribution rights [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
2014	75,000
2015	75,000
2016	75,000
2017	75,000
Beyond	131,250
Amortized cost of assets	431,250
Pure Guild brand rights [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
2014	14,780
2015	14,780
2016	14,780
2017	14,780
Beyond	7,396
Amortized cost of assets	66,516
Mexican Customer list [Member]	'
Finite-Lived Intangible Assets [Line Items]	'
2014	103,500
2015	103,500
2016	103,500
2017	103,500
Beyond	398,338
Amortized cost of assets	$812,338

ACCOUNTS_PAYABLE_AND_ACCRUED_E2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Accrued expenses:	'	'
Advertising and marketing	$12,264	$60,264
Commissions	261,151	362,346
Director services	18,750	'
Facilities	12,535	38,023
Fees/interest	21,003	19,012
Investor relations	390,703	44,000
Production materials	144,543	'
Other	'	61,807
Personnel	70,000	109,930
Professional fees	15,000	9,500
Total Accrued expenses	$945,949	$704,882

OTHER_CURRENT_LIABILITIES_Deta

OTHER CURRENT LIABILITIES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
OTHER CURRENT LIABILITIES [Abstract]	'	'
Customer deposits	$29,959	$22,689
Credit cards	47,597	117,006
VAT Taxes payable	142,848	78,989
Current portion of long term debt	10,770	8,723
Insurance premium financing	4,770	'
Vendor financing	50,338	'
Other current liabilities	$286,282	$227,407

SHAREHOLDER_LOANS_Details

SHAREHOLDER LOANS (Details) (USD $)	12 Months Ended			1 Months Ended	12 Months Ended			12 Months Ended		1 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 10, 2012	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 10, 2012	Dec. 31, 2013	Dec. 31, 2012	Jan. 31, 2013	Jan. 20, 2013
				Shareholder/Consultant [Member]	Shareholder/Consultant [Member]	Shareholder/Consultant [Member]	Shareholder/Consultant [Member]	Daniel Khesin [Member]	Daniel Khesin [Member]	Gamma Investors [Member]	Gamma Investors [Member]
				Unsecured Debt [Member]	Unsecured Debt [Member]	Unsecured Debt [Member]	Unsecured Debt [Member]	Unsecured Debt [Member]	Unsecured Debt [Member]	Unsecured Debt [Member]	Unsecured Debt [Member]
Related Party Transaction [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Debt instrument, face amount	'	'	$53,900	'	'	'	$314,000	'	$39,000	'	$70,000
Annual rate	5.95%	'	'	'	'	'	'	'	'	'	3.00%
Debt instrument, maturity date	30-Jun-14	'	'	'	'	11-Dec-13	'	'	25-Dec-13	20-Aug-13	'
Debt instrument, additional borrowings	'	'	'	'	240,000	'	'	'	'	'	'
Repayments of notes	'	'	'	'	'	'	'	39,000	'	'	'
Shareholder loans	'	353,000	'	'	554,000	'	'	'	'	'	'
Conversion of shareholder loans to equity, shares	'	'	'	456,000	'	'	'	'	'	'	'
Conversion of shareholder loans to equity	554,000	'	'	843,600	'	'	'	'	'	'	'
Loss on extinguishment of debt - shareholder	$289,600	'	'	$289,600	'	'	'	'	'	'	'

DEBT_FINANCING_Details

DEBT FINANCING (Details) (USD $)	1 Months Ended	12 Months Ended
	Apr. 30, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 10, 2012	Apr. 06, 2012
DEBT FINANCING [Abstract]	'	'	'	'	'
Credit facility maximum borrowing capacity	'	$1,000,000	'	'	$1,500,000
Credit facility amount outstanding	'	582,383	448,658	'	580,000
Credit facility interest rate	'	'	'	'	8.00%
The percentage of qualified accounts receivable that determines the amount of allowable advances under the credit facility	'	'	'	'	70.00%
The percentage of total finished goods inventory that determines the amount of allowable advances under the credit facility	'	'	'	'	40.00%
Prime interest rate spread	3.00%	'	'	'	'
Percentage rate for monitoring and other fees per terms of credit facility agreement	'	'	'	'	1.75%
Debt instrument, maturity date	'	30-Jun-14	'	'	'
The per annum referral fee percentage rate per terms of credit facility agreement	'	'	'	'	4.00%
Number of years referral fee is in effect	'	'	'	'	3
Additional amount that can be borrowed on facility	'	175,115	'	'	'
Debt instrument, face amount	'	'	'	53,900	'
Monthly payment amount	'	1,041	'	'	'
Annual rate	'	5.95%	'	'	'
Initial term of loan	'	'60 months	'	'	'
Interest expense	'	$3,138	'	'	'

DEBT_FINANCING_Schedule_of_the

DEBT FINANCING (Schedule of the Principal Payout of Debt) (Details) (USD $)	Dec. 31, 2013
Debt Instrument [Line Items]	'
2014	$10,770
2015	11,429
2016	12,127
2017	12,869
Total long-term debt	$47,195

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Leases for Office and Production Facilities) (Details) (USD $)	12 Months Ended		3 Months Ended			1 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2013	Oct. 31, 2012	Oct. 31, 2012	Dec. 31, 2013
			Miami Beach, FL (HQ) [Member]	Deerfield Beach, Florida (Production) [Member]	Deerfield Beach, Florida (Production) [Member]	Pompano, FL (Production) [Member]	Ashville, North Carolina (Sales) [Member]	Ashville, North Carolina (Sales) [Member]
				sqft		sqft	sqft
Operating Leased Assets [Line Items]	'	'	'	'	'	'	'	'
Operating leases, rent expense, monthly, net	'	'	$5,700	$27,000	'	$6,350	$4,725	'
Operating leases, rent expense, annually, net	'	'	68,400	'	'	'	'	'
Lease expiration period	'	'	'	'	'	15-Oct-12	31-Dec-15	'
Area of real estate space	'	'	'	50,000	'	13,137	1,875	'
Increase amount of real estate acquired	'	'	'	'	'	'	1,525	'
Operating lease expiration period	'	'	'	'22 months	'	'	'	'
Operating leases, rent expense, monthly , first six months	'	'	'	20,000	'	'	'	'
Rent expense	408,491	299,406	'	'	'	'	'	'
2014	245,695	'	'	'	189,000	'	'	56,695
2015	56,695	'	'	'	'	'	'	56,695
2016	'	'	'	'	'	'	'	'
Beyond	'	'	'	'	'	'	'	'
Total	$302,390	'	'	'	$189,000	'	'	$113,390

COMMITMENTS_AND_CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Pending and Threatened Litigation and Purchase Commitments) (Details) (USD $)	1 Months Ended	12 Months Ended				12 Months Ended
	Jun. 30, 2011	Dec. 31, 2013	Dec. 31, 2011	Dec. 31, 2012	Dec. 02, 2012	Dec. 31, 2012
						Related Party Former Employee Litigation [Member]
Loss Contingencies [Line Items]	'	'	'	'	'	'
Accrued value of loss contingency	'	$22,264	'	$162,764	$77,500	$85,000
Amount paid for prior services	20,000	'	500	'	'	'
Litigation for recission, number of shares	23,000	'	20,000	'	'	40,000
Long-term Purchase Commitment [Line Items]	'	'	'	'	'	'
Purchase orders outstanding	'	685,137	'	'	'	'
Fees required to pay by company if contract terminated	'	$2,000,000	'	'	'	'

COMMITMENTS_AND_CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Employment Agreement) (Details) (Chief Executive Officer [Member], USD $)	0 Months Ended
	Dec. 16, 2013
Chief Executive Officer [Member]	'
Related Party Transaction [Line Items]	'
Base annual salary	$250,000
Initial term expiration	31-Dec-18
Renewal term periods	'1 year
Salary percent increase for any one quarterly period following a quarterly period in which the Company is profitable	20.00%
Value of common stock payment included in base salary	$50,000
Disability compensation percentage	25.00%
Disability compensation term	'10 years
Lump sum payment calculated upon number of months of annual base salary, payable upon termination or non-renewal notice	'42 months
Non-competition period	'6 months

EQUITY_Common_Stock_Details

EQUITY (Common Stock) (Details) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Sep. 30, 2012

Dec. 31, 2012

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Jun. 30, 2013

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Jun. 30, 2013

Sep. 30, 2013

Dec. 31, 2013

Two Founders [Member]

Two Founders [Member]

Nutra Origin License [Member]

IR Firm [Member]

IR Firm [Member]

IR Firm [Member]

Directors [Member]

Directors [Member]

Directors [Member]

Four Private Investors [Member]

Two Associates [Member]

Private Investors [Member]

Private Placement [Member]

Five Individuals [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Directors [Member]

Four Private Investors [Member]

Five Individuals [Member]

Directors [Member]

Four Private Investors [Member]

Five Individuals [Member]

Stockholders Equity Note [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued as compensation for service

'

'

'

31,367

28,000

108,764

28,182

'

'

'

'

15,385

52,700

80,000

20,000

15,000

7,500

5,000

'

31,779

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock, per share

'

'

'

$3.32

'

'

'

'

'

'

$2.50

$3.25

$1.76

$1.75

$2.20

$2.02

'

$3.20

'

$1.66

$1.12

$1.60

'

$2.20

$2

$3.10

$1.75

'

$1.91

$3.20

$2.80

$3.20

$2.61

'

$2.31

Issuance of common stock for services

'

'

'

$104,138

$69,600

$241,528

$89,182

$687,980

$478,448

'

'

$50,000

$92,550

$140,000

$44,000

$30,300

$16,350

$16,000

'

$52,721

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercised

'

'

'

'

'

4,070

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercised, shares

'

'

'

'

'

40,700

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee/associate compensation, per share

$1.50

$2.11

$2.50

$3.36

$2.80

$2.60

$3.40

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1

'

'

'

'

'

$1.15

'

Employee/associate compensation, shares

28,433

11,765

15,300

'

'

38,514

8,824

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenue allowance

42,649

24,824

38,250

'

'

100,000

30,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of preferred stock to common stock, shares

'

'

'

'

'

'

'

'

'

450,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of convertible preferred stock, shares

550,000

'

'

450,000

'

'

'

'

450,000

450,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock surrendered, shares

'

'

'

5,000

20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock surrendered, value

'

'

'

16,800

56,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Professional fees

'

'

'

'

'

'

'

'

'

'

146,400

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net proceeds from issuance of common stock

'

'

'

'

'

'

'

'

'

'

585,600

'

'

'

'

'

'

'

410,000

'

10,000

3,144,000

190,336

'

'

'

'

'

'

'

'

'

'

'

'

Shares issued, shares

'

'

'

'

'

'

'

'

'

'

292,000

'

'

'

'

'

'

'

381,192

'

8,943

1,965,000

94,679

'

'

'

'

'

'

'

'

'

'

'

'

Gross proceeds

'

'

'

'

'

'

'

'

'

'

732,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Offering fees

'

'

'

'

'

'

'

$31,260

$146,400

'

'

'

'

'

'

'

'

'

$31,260

'

'

$151,051

'

'

'

'

'

'

'

'

'

'

'

'

'

Restriction period under the Securities Purchase Agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'9 months

'

'

'

'

'

'

'

'

'

'

'

'

'

Restriction price per share under the Securities Purchase Agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1.60

'

'

'

'

'

'

'

'

'

'

'

'

'

Percent restriction of aggregated issuances under the Securities Purchase Agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

19.99%

'

'

'

'

'

'

'

'

'

'

'

'

'

EQUITY_Warrants_Details

EQUITY (Warrants) (Details) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Warrant [Member]	'	'
Warrants	'	'
Outstanding, beginning balance	253,893	253,893
Issued	'	'
Exercised	'	'
Forfeited	'	'
Outstanding, ending balance	253,893	253,893
Exercisable	253,893	253,893
Weighted average exercise price	'	'
Outstanding, beginning balance	$4.67	$4.67
Issued	'	'
Exercised	'	'
Forfeited	'	'
Outstanding, ending balance	$4.67	$4.67
Exercisable	$4.67	$4.67
Weighted average remaining contractual term	'	'
Outstanding, beginning balance	'3 years 2 months 16 days	'4 years 2 months 16 days
Outstanding, ending balance	'2 years 2 months 19 days	'3 years 2 months 16 days
Aggregate intrinsic value	'	'
Outstanding, beginning balance	'	'
Outstanding, ending balance	'	'
Exercisable	'	'

EQUITY_Stock_Options_Details

EQUITY (Stock Options) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2009	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
				Issuance of Equity Private Placement Memorandum [Member]	Consulting Agreement [Member]	Consulting Agreement [Member]	Consulting Agreement [Member]
Options	'	'	'	'	'	'	'
Outstanding, beginning	32,633	73,333	'	'	'	'	'
Issued	'	'	'	200,000	'	'	'
Exercised	'	-40,700	'	'	'	'	'
Forfeited	'	'	'	'	'	'	'
Outstanding, ending	32,633	32,633	73,333	'	'	'	'
Options exercisable	32,633	32,633	'	'	'	'	'
Weighted average exercise price, beginning	$0.10	$0.10	'	'	'	'	'
Weighted average exercise price, issued	'	'	'	$0.10	'	'	'
Weighted average exercise price, exercised	'	$0.10	'	'	'	'	'
Weighted average exercise price, forfeited	'	'	'	'	'	'	'
Weighted average exercise price, ending	$0.10	$0.10	$0.10	'	'	'	'
Options exercisable, weighted average exercise price	$0.10	$0.10	'	'	'	'	'
Weighted average remaining contractual term	'1 year 1 month 28 days	'2 years 1 month 28 days	'3 years	'5 years	'	'	'
Options exercisable, weighted average remaining contractual term	'1 year 1 month 28 days	'2 years 1 month 28 days	'	'	'	'	'
Options outstanding, Aggregate beginning balance	$107,690	$264,000	'	'	'	'	'
Options outstanding, Aggregate ending balance	76,688	107,690	264,000	'	'	'	'
Options exercisable, intrinsic value	76,688	107,690	'	'	'	'	'
Price per share	'	'	'	$2.50	'	'	'
Grant date fair value	'	'	'	480,000	'	'	'
Exercisable number of shares per quarter, maximum	'	'	'	20,000	'	'	'
Consulting services	'	'	'	'	$128,000	$192,000	$160,000

EQUITY_Preferred_Stock_Details

EQUITY (Preferred Stock) (Details)	1 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
EQUITY [Abstract]	'	'	'
Number of voting rights per share of Series A Preferred Stock	'	0.2	'
Conversion of preferred stock into common stock	5,500,000	'	4,500,000
Number of common shares issued in conversion	550,000	'	450,000

INCOME_TAXES_Schedule_for_Prov

INCOME TAXES (Schedule for Provision for Income Taxes) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Current:	'	'
Federal	'	'
State	'	'
Non-U.S.	'	'
Current provision (benefit)	'	'
Deferred:	'	'
Federal	-906,445	-1,259,260
State	-91,319	-95,418
Non-U.S.	-17,109	-854
Increase in valuation allowance	1,014,873	1,355,532
Total provision (benefit) for income taxes	'	'

INCOME_TAXES_Reconciliation_fo

INCOME TAXES (Reconciliation for Provision for Income Taxes Percentage) (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
INCOME TAXES [Abstract]	'	'
Expected provision (benefit) at statutory rate	-35.00%	-35.00%
State taxes	-3.60%	-3.60%
Non-U.S.	'	'
Non-deductible expenses	'	'
Increase in valuation allowance	38.60%	38.60%
Total provision (benefit) for income taxes	'	'

INCOME_TAXES_Schedule_for_Defe

INCOME TAXES (Schedule for Deferred Tax Assets and Liabilities) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:	'	'
Net operating loss carry-forwards	$2,377,321	$1,670,009
Stock-based compensation	492,937	216,193
Amortization	13,673	'
Accrued interest	2,111	2,075
Total deferred tax assets	2,886,042	1,888,277
Valuation allowance	-2,886,042	-1,888,277
Net deferred tax assets	'	'
Increase in valuation allowance	1,014,873	1,355,532
Operating Loss Carryforwards [Line Items]	'	'
Net operating loss carryforwards	$5,165,561	$4,329,251
Minimum [Member]	'	'
Operating Loss Carryforwards [Line Items]	'	'
Net operating loss carry forward expiration dates	31-Dec-30	'
Maximum [Member]	'	'
Operating Loss Carryforwards [Line Items]	'	'
Net operating loss carry forward expiration dates	31-Dec-32	'

2009_EQUITY_INCENTIVE_PLAN_Det

2009 EQUITY INCENTIVE PLAN (Details) (2009 Equity Incentive Plan [Member], USD $)	12 Months Ended
	Dec. 31, 2013
2009 Equity Incentive Plan [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares authorized under plan	500,000
Maximum number of shares issuable to one employee during one calendar year	100,000
The fair market value threshold, that if achieved by option holders, will cause any excess options to be treated as Nonstatutory Stock Options	$100,000
Term of Option, unless otherwise stated in Option Agreement (in years)	'10 years
The term for options held by holders of more than 10% of the total combined voting power of all classes of stock of the Company and any Parent or Subsidiary (in years)	'5 years

SIGNIFICANT_CUSTOMERS_Details

SIGNIFICANT CUSTOMERS (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
			Customer B [Member]	Customer B [Member]	Customer C [Member]	Customer C [Member]	Revita [Member]	Revita Cor [Member]	Spectral DNC-N [Member]	Revita, Revita Cor and Spectral DNC-N [Member]	Top Ten Customers [Member]
			Accounts Receivable [Member]	Sales Amount [Member]	Accounts Receivable [Member]	Sales Amount [Member]	Sales Amount [Member]	Sales Amount [Member]	Sales Amount [Member]	Sales Amount [Member]	Sales Amount [Member]
Concentration Risk [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Sales Amount	'	'	'	$1,189,899	'	$1,470,277	'	'	'	'	'
Accounts Receivable	$2,229,329	$2,125,641	$95,008	'	$459,875	'	'	'	'	'	'
Concentration risk percentage	'	'	4.00%	10.00%	18.00%	13.00%	10.00%	10.00%	9.00%	40.00%	41.00%

SIGNIFICANT_VENDORS_Details

SIGNIFICANT VENDORS (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Concentration Risk [Line Items]	'	'
Accounts payable	$2,230,723	$2,327,540
Vendor A [Member] | Purchase Amount [Member]	'	'
Concentration Risk [Line Items]	'	'
Purchase Amount	533,968	1,074,456
Concentration risk percentage	13.00%	19.00%
Vendor A [Member] | Accounts Payable [Member]	'	'
Concentration Risk [Line Items]	'	'
Accounts payable	126,027	84,369
Concentration risk percentage	11.00%	5.00%
Vendor C [Member] | Purchase Amount [Member]	'	'
Concentration Risk [Line Items]	'	'
Purchase Amount	764,357	732,737
Concentration risk percentage	19.00%	13.00%
Vendor C [Member] | Accounts Payable [Member]	'	'
Concentration Risk [Line Items]	'	'
Accounts payable	$87,782	$157,916
Concentration risk percentage	8.00%	9.00%

GEOGRAPHIC_REVENUE_REPORTING_D

GEOGRAPHIC REVENUE REPORTING (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]	'	'
Net revenue	$13,651,661	$11,224,424
Furniture and Equipment, net	206,958	293,720
North America [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net revenue	7,046,473	7,185,641
Furniture and Equipment, net	112,456	169,859
International [Member]	'	'
Segment Reporting Information [Line Items]	'	'
Net revenue	6,605,188	4,038,783
Furniture and Equipment, net	$120,068	$123,861

ACQUISITION_OF_MEXICAN_DISTRIB2

ACQUISITION OF MEXICAN DISTRIBUTOR (Details) (USD $)	12 Months Ended			1 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2012	Dec. 11, 2012	Dec. 31, 2012
	Net Revenues Equal or Greater than $4,000,000 [Member]	Net Revenues Equal or Greater than $5,000,000 [Member]	Net Revenues Equal or Greater than $6,000,000 [Member]	Dr. Tamez [Member]	DS Laboratories S. A. DE C. V. [Member]
Business Acquisition [Line Items]	'	'	'	'	'
Percentage of business acquired	'	'	'	'	100.00%
Number of shares issued for business acquisition	50,000	50,000	50,000	'	450,000
Per share value issued, business combination	'	'	'	'	$2.60
Contingent consideration, liability	'	'	'	'	$132,600
Purchase Mexican distributor, shares	'	'	'	'	600,000
Additional shares of common stock issued	'	'	'	'	150,000
Equity Instruments delivered, value	4,000,000	5,000,000	6,000,000	'	1,170,000
Debt forgiveness by company	'	'	'	'	38,415
Professional fees	'	'	'	'	5,000
Fair value of the assets and liabilities acquired:	'	'	'	'	'
Cash	'	'	'	'	127,321
Inventory	'	'	'	'	159,379
Property and equipment, net	'	'	'	'	126,628
Accounts receivable	'	'	'	'	380,522
Prepaid and other current assets	'	'	'	'	87,125
Other current liabilities	'	'	'	'	-50,678
Goodwill	'	'	'	'	34,444
Accounts payable	'	'	'	'	-455,726
Customer list	'	'	'	'	932,000
Total net assets acquired	'	'	'	'	1,341,015
Aggregate purchase price	'	'	'	'	1,341,015
Annual compensation	'	'	'	60,000	'
Deferred compensation cost	'	'	'	50,000	'
Deferred Profit Sharing Percent	'	'	'	30.00%	'
Performance Agreement Term	'	'	'	'5 years	'
Profit Sharing Participation Termination Payment	'	'	'	500,000	'
Change In Control Contingent Payment	'	'	'	$500,000	'

ACQUISITION_OF_MEXICAN_DISTRIB3

ACQUISITION OF MEXICAN DISTRIBUTOR (Pro-Forma Consolidated Statement of Operations) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenue	$13,651,661	$11,224,424
Net Income (Loss) Attributable to Shareholders of DS Healthcare Group, Inc	-3,209,431	-3,606,744
Net (loss) income per common share: Basic and diluted	($0.25)	($0.33)
Weighted average shares outstanding: Basic and diluted	12,711,417	11,106,145
Pro Forma Financial Statements [Member]	'	'
Revenue	'	12,398,592
Net Income (Loss) Attributable to Shareholders of DS Healthcare Group, Inc	'	($3,623,773)
Net (loss) income per common share: Basic and diluted	'	($0.03)
Weighted average shares outstanding: Basic and diluted	'	11,507,784

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

3 Months Ended

Apr. 30, 2012

Jun. 30, 2011

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Apr. 06, 2012

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 24, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Directors [Member]

Directors [Member]

Directors [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Minimum [Member]

Maximum [Member]

Directors [Member]

SUBSEQUENT EVENTS [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount paid for prior services

'

$20,000

'

'

'

'

'

'

$500

'

'

'

'

'

'

'

'

'

'

Litigation for recission, number of shares

'

23,000

'

'

'

'

'

'

20,000

'

'

'

'

'

'

'

'

'

'

Subsequent Event [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility maximum borrowing capacity

'

'

'

'

'

'

1,000,000

'

'

1,500,000

'

'

'

'

'

1,000,000

'

'

'

Credit facility term

'

'

'

'

'

'

'

'

'

'

'

'

'

'3 months

'

'

'

'

'

Debt instrument, maturity date

'

'

'

'

'

'

30-Jun-14

'

'

'

'

'

'

30-Jun-14

'

'

'

'

'

Credit facility interest rate

'

'

'

'

'

'

'

'

'

8.00%

'

'

'

'

'

8.00%

'

'

'

Prime interest rate spread

3.00%

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

'

'

'

'

'

Percentage rate for monitoring and other fees per terms of credit facility agreement

'

'

'

'

'

'

'

'

'

1.75%

'

'

'

'

'

1.75%

'

'

'

The percentage of qualified accounts receivable that determines the amount of allowable advances under the credit facility

'

'

'

'

'

'

'

'

'

70.00%

'

'

'

'

'

70.00%

'

'

'

The percentage of total finished goods inventory that determines the amount of allowable advances under the credit facility

'

'

'

'

'

'

'

'

'

40.00%

'

'

'

'

'

40.00%

'

'

'

Number of common shares the defendant agreed to return to Company

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

Number of common shares remaining, 60% subject to a one year lock up agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

Percentage of common shares subject to a one year lock up agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

'

'

'

'

'

Issuance of common stock for services, shares

'

'

31,367

28,000

108,764

28,182

'

'

'

'

15,000

7,500

5,000

'

221,000

'

'

'

3,750

Issuance of common stock for services

'

'

$104,138

$69,600

$241,528

$89,182

$687,980

$478,448

'

'

$30,300

$16,350

$16,000

'

$494,595

'

'

'

$8,325

Price per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2.20

$2.44

$2.22